<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>c35338exv2w1.htm
<DESCRIPTION>STOCK PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE>exv2w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;2.1</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">STOCK PURCHASE AGREEMENT
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">by and among

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">ZIMMER, INC.

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">ZIMMER HOLDINGS FRANCE S.A.S.

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">ABBOTT LABORATORIES

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">and ABBOTT FRANCE S.A.S.

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">with respect to all

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">outstanding capital stock of

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">ABBOTT SPINE INC.

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">and

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">ABBOTT SPINE S.A.

</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">dated as of September&nbsp;4, 2008
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>TABLE OF CONTENTS</B></U>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE I SALE OF SHARES AND CLOSING</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">1.01 Purchase and Sale</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">1.02 Purchase Price</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">1.03 Tax Treatment of Purchase Price</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">1.04 Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">1.05 Closing Deliveries by Sellers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">1.06 Closing Deliveries by Purchasers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">1.07 Closing Working Capital</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">1.08 Adjustment of Purchase Price</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE II REPRESENTATIONS AND WARRANTIES OF SELLERS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.01 Organization and Authority of Sellers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.02 Organization, Authority and Qualification of Spine Entities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.03 Capital Stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.04 No Conflicts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.05 Governmental Consents and Approvals</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.06 Financial Statements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.07 Liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.08 Litigation; Insurance Claims</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.09 Assets; Inventory</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.10 Legal Compliance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.11 Labor and Employment Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.12 Taxes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.13 Intellectual Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.14 Employee Benefits</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.15 Contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.16 Operation of Business</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.17 Regulatory Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.18 Securities Purchase Agreement Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.19 Spine Data Room</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">2.20 Disclaimer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE III REPRESENTATIONS AND WARRANTIES OF PURCHASERS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">3.01 Organization and Authority of Purchasers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">3.02 No Conflicts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">3.03 Governmental Consents and Approvals</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">3.04 Litigation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">3.05 Capital Adequacy, Solvency</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">3.06 Availability of Funds</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">3.07 Representations Acknowledgment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE IV COVENANTS AND AGREEMENTS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.01 Conduct of the Business</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.02 Access to Information; Confidentiality</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.03 Regulatory and Other Authorizations; Notices and Consents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.04 Affiliate Transactions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.05 Fulfillment of Conditions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.06 Termination of Seller Insurance Coverage</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.07 Use of Seller Brand</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.08 Credit and Performance Support Obligations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.09 Mixed Contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.10 Consultation with Business Employees&#146; Representatives</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.11 Transition Services Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.12 Contact with Customers and Suppliers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.13 Distribution of Cash Balances</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.14 Due Diligence; Reliance on Experts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.15 Assets and Liabilities Not Held by Spine Entities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.16 Further Assurances; Post-Closing Cooperation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.17 Transaction Costs</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.18 International Purchaser</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">4.19 Enovia Software</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE V EMPLOYEE MATTERS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.01 Employee Benefit Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">5.02 Non-Solicitation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE VI TAXES</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">6.01 Sellers&#146; Indemnifications</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">6.02 Purchasers&#146; Indemnification</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">6.03 Refunds or Credits</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">6.04 Tax Returns</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">6.05 Mutual Cooperation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">6.06 Contests</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">6.07 Transfer Taxes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">6.08 Section&nbsp;338</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">6.09 Survival of Obligations and Sole Remedy</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE VII CONDITIONS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">7.01 Conditions to the Obligations of Purchasers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">7.02 Conditions to the Obligations of Sellers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE VIII TERMINATION</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">8.01 Termination</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">8.02 Effect of Termination</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE IX INDEMNIFICATION AND SURVIVAL</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.01 Survival of Representations, Warranties, Covenants and Agreements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.02 Indemnification</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.03 Indemnity Procedures</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">48</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.04 Adjustment to Purchase Price</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.05 Insurance Offset</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.06 Exclusivity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->ii&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.07 Preservation of Rights</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">9.08 Government Investigations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE X DEFINITIONS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">10.01 Definitions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE XI MISCELLANEOUS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.01 Assignment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.02 Public Announcements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.03 Severability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.04 No Third Party Beneficiaries</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.05 Waiver</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.06 Governing Law</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.07 Jurisdiction</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.08 Waiver of Jury Trial</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.09 Specific Performance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.10 Headings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.11 Counterparts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.12 Further Documents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.13 Notices</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.14 Construction</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">64</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.15 Ratification of this Agreement by International Seller</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">65</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.16 Exchange Rates</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">65</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">11.17 Entire Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">65</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBITS
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="15%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="80%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">EXHIBIT A
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Transition Services Agreement</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">EXHIBIT B
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press Release</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->iii&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This STOCK PURCHASE AGREEMENT, dated as of September&nbsp;4, 2008 is made and entered into by and
among Zimmer, Inc., a Delaware corporation (&#147;<U>U.S. Purchaser</U>&#148;); subject to the provisions of
<U>Section&nbsp;4.18</U> hereof, Zimmer Holdings France S.A.S. (&#147;<U>International Purchaser</U>&#148; and
together with U.S. Purchaser, &#147;<U>Purchasers</U>&#148;); Abbott Laboratories, an Illinois corporation
(&#147;<U>U.S. Seller</U>&#148;); and, subject to the provisions of <U>Section&nbsp;11.15</U> hereof, Abbott
France S.A.S., a <I>soci&#233;t&#233; par actions simplifi&#233;e </I>organized under the laws of the Republic of France,
having its registered office at 10 Rue d&#146;Arcueil, BP 90233, 94528 Rungis Cedex, France, and
registered with the <I>Registre du Commerce et des Soci&#233;t&#233;s </I>of Cr&#233;teil under identification number
(<I>&#147;num&#233;ro d&#146;identification unique&#148;) </I>602 950 206 (&#147;<U>International Seller</U>&#148; and together with
U.S. Seller, &#147;<U>Sellers</U>&#148;). Capitalized terms not otherwise defined herein have the meanings
set forth in <U>Section&nbsp;10.01</U> hereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, U.S. Seller owns the issued and outstanding common stock, $0.01 par value per share,
of Abbott Spine Inc., a Delaware corporation (&#147;<U>ASI</U>&#148;) (such shares being referred to herein
as the &#147;<U>ASI Shares</U>&#148;); and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, International Seller together with the Other Sellers own all of the issued and
outstanding common stock, 1 Euro par value per share, of Abbott Spine S.A., a <I>soci&#233;t&#233; anonyme</I>
organized under the laws of the Republic of France, having its registered office at 23 Parvis des
Chartrons &#150; Cit&#233; Mondiale &#150; 33080 Bordeaux, France and registered with the <I>Registre du Commerce et
des Soci&#233;t&#233;s </I>of Bordeaux under identification number (<I>&#147;num&#233;ro d&#146;identification unique&#148;) </I>424 884 682
(&#147;<U>ASSA</U>&#148;) (such shares being referred to herein as the &#147;<U>ASSA Shares</U>&#148; and together
with the ASI Shares, the &#147;<U>Shares</U>&#148;); and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Sellers desire to sell and cause the Other Sellers to sell, and Purchasers desire to
purchase, the Shares on the terms and subject to the conditions set forth in this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth in this
Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties hereto agree as follows:
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE I<BR>
SALE OF SHARES AND CLOSING
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.01 <U>Purchase and Sale</U>. Upon the terms and subject to the conditions set forth in this Agreement, at the Closing:
(a)&nbsp;U.S. Seller shall sell, convey, assign and transfer to U.S. Purchaser the ASI Shares, and the
U.S. Purchaser shall purchase all of the U.S. Seller&#146;s right, title and interest in and to the ASI
Shares, free and clear of all Encumbrances other than Encumbrances
created or suffered to exist by
Purchasers; (b)&nbsp;International Seller shall sell, convey, assign and transfer to International
Purchaser the ASSA Shares owned by International Seller, and the International Purchaser shall
purchase all of the International
Seller&#146;s right, title and interest in and to such ASSA Shares, free and clear of all
Encumbrances other than Encumbrances created or suffered
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to exist by Purchasers; and (c)&nbsp;Sellers
shall cause each Other Seller to, and each Other Seller shall, sell, convey, assign and transfer to
the International Purchaser the ASSA Share owned by such Other Seller, and International Purchaser
shall purchase the Other Sellers&#146; right, title and interest in and to the ASSA Share owned by each
Other Seller, free and clear of all Encumbrances other than Encumbrances created or suffered to
exist by Purchasers.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.02 <U>Purchase Price</U>. Subject to the terms and conditions of this Agreement, at the Closing, Purchasers shall
pay, in consideration for the purchase of the Shares pursuant to<U> Section&nbsp;1.01</U>, in cash
$360,000,000 (the &#147;<U>Purchase Price</U>&#148;). The payment of the Purchase Price shall not be
reduced by any withholdings or deductions except to the extent required by United States or foreign
Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.03 <U>Tax Treatment of Purchase Price</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Not later than five (5)&nbsp;days after the date of this Agreement, Sellers shall deliver to
Purchasers for their review and comment an allocation of the Purchase Price to the Shares based on
an estimate of the fair market values of the ASI Shares and ASSA Shares. If Sellers and Purchasers
are unable to reach agreement on the allocation of the Purchase Price within thirty (30)&nbsp;days
following the delivery of the allocation to the Purchasers, the allocation of Purchase Price shall
be determined by an internationally-recognized independent accounting firm mutually selected by
Sellers and Purchasers (&#147;<U>Independent Expert</U>&#148;) using customary valuation methodologies;
provided, however, that the Independent Expert shall make its determination within thirty (30)&nbsp;days
following the Closing Date. The determination made by the Independent Expert shall be, absent
manifest error, final and binding on Purchasers and Sellers. The fees and expenses of the
Independent Expert shall be shared equally between Sellers and Purchasers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Purchasers, Sellers, Other Sellers and each of their respective Affiliates shall: (i)
treat the amounts allocated to each of ASI and ASSA pursuant to <U>Section&nbsp;1.03(a)</U> as the
purchase price of the respective entity for Tax purposes; (ii)&nbsp;be bound by the allocations
determined pursuant to <U>Section&nbsp;1.03(a)</U> for purposes of determining any Taxes; and (iii)
prepare and file, and cause their Affiliates to prepare and file, their Tax Returns on a basis
consistent with these allocations. None of Purchasers, Sellers, Other Sellers or their respective
Affiliates shall take any position inconsistent with these allocations in any Tax Return, in any
refund claim, in any litigation, or otherwise unless required by final determination by an
applicable Taxing Authority. In the event that an allocation is disputed by any Taxing Authority,
the party receiving notice of the dispute shall promptly notify the other parties hereto, and
Purchasers and Sellers agree to use commercially reasonable efforts to defend such allocations in
any audit or similar proceeding.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.04 <U>Closing</U>. Subject to the terms and conditions of this Agreement, the sale and purchase of the Shares
contemplated by this Agreement shall take place at a closing (the &#147;<U>Closing</U>&#148;), which shall
take place at the offices of Skadden, Arps, Slate,
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Meagher &#038; Flom LLP, 333 West Wacker Drive,
Chicago, Illinois 60606 or at such other place as Purchasers and Sellers mutually agree in writing,
at 10:00&nbsp;A.M. local time, on the third (3<SUP style="font-size: 85%; vertical-align: text-top">rd</SUP>) Business Day following the satisfaction or
waiver of each of the conditions set forth in <U>Article&nbsp;VII</U> (excluding conditions that, by
their terms, cannot be satisfied until the Closing, but the Closing shall be subject to the
satisfaction or waiver of those conditions) or at such other time or date as Purchasers and Sellers
may mutually agree in writing (the &#147;<U>Closing Date</U>&#148;). Unless the parties otherwise agree in
writing, the Closing shall be deemed to have occurred at 12:01&nbsp;a.m. local time in each applicable
jurisdiction on the Closing Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.05 <U>Closing Deliveries by Sellers</U>. At the Closing, Sellers shall deliver, or cause to be delivered, to the applicable
Purchaser:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;a certificate or certificates representing the ASI Shares, duly endorsed in blank or
accompanied by duly executed stock powers endorsed in blank;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;duly completed and executed share transfer forms (<I>ordre de mouvement) </I>providing for the
transfer of legal title to and possession of all ASSA Shares to the International Purchaser along
with the declaration for Tax registration (<I>formulaire cerfa no 2759 DGI) </I>pursuant to section 726-I
of the French Tax Code (<I>le Code General des Imp&#244;ts);</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;the share transfer register (<I>registre des mouvements de titres) </I>and the shareholders&#146;
accounts (<I>comptes d&#146;actionnaires) </I>of ASSA updated to evidence that the transfers of all the ASSA
Shares in favor of the International Purchaser have been duly recorded;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;the Transition Services Agreement, as executed by Sellers;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;resignations of each director of the Spine Entities, effective as of Closing;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;a certification of non-foreign status for U.S. Seller in the form and manner which
complies with the requirements of Section&nbsp;1445 of the Code and the regulations promulgated
thereunder;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;a receipt for the Purchase Price;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;the certificate described in <U>Section&nbsp;7.01(a)</U>;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;resolutions of ASSA revoking all powers of attorney granted to any officers, directors, or
employees of U.S. Seller or any of its Affiliates who are not Business Employees and a certificate
of an officer of U.S. Seller that such revocation has been communicated to all of such officers,
directors and employees;
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;termination of the Contrats de Pret a la Consommation entered into between International
Seller and each of the Other Sellers;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;copies of the opinions of the works councils of International Seller and ASSA relating to
the consultations contemplated by <U>Section&nbsp;11.15</U>; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;for each of ASI and SNAC, a good standing certificate, dated within five (5)&nbsp;Business Days
prior to the Closing Date, issued by the Delaware Secretary of State&#146;s office, and for ASSA, a Kbis
extract from the commercial register, dated within five (5)&nbsp;Business Days prior to the Closing
Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.06 <U>Closing Deliveries by Purchasers</U>. At the Closing, Purchasers shall deliver, or cause to be delivered, to the applicable
Purchaser:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;the Purchase Price, by wire transfer in immediately available funds to one or more bank
accounts designated in writing by U.S. Seller no later than three (3)&nbsp;Business Days before the
Closing Date;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;the Transition Services Agreement as executed by Purchasers; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;the certificate described in <U>Section&nbsp;7.02(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.07 <U>Closing Working Capital</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Within thirty (30)&nbsp;days after the Closing Date, Sellers shall prepare, or cause to be
prepared, and deliver to Purchasers an unaudited statement setting forth Sellers&#146; calculation of
Working Capital as of the Closing Date (the &#147;<U>Closing Working Capital Statement</U>&#148;), which
shall set forth Sellers&#146; calculation of Working Capital as of the Closing Date (&#147;<U>Closing
Working Capital</U>&#148;). Closing Working Capital and Final Working Capital shall be reduced by an
amount equal to the asset value of the inventory described in <U>Schedule&nbsp;2.07</U>;
<U>provided</U> that if a reserve with respect to such inventory has been included in Closing
Working Capital or Final Working Capital, then such reduction shall not be made to the extent it
duplicates the reserve.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Upon receipt from Sellers, Purchasers shall have thirty (30)&nbsp;days to review the Closing
Working Capital Statement (the &#147;<U>Review Period</U>&#148;). If
Purchasers disagree with Sellers&#146; computation of Closing Working Capital, Purchasers may, on
or prior to the last day of the Review Period, deliver a notice to Sellers (a &#147;<U>Notice of
Objection</U>&#148;), which sets forth their objections to Sellers&#146; calculation of Closing Working
Capital. Any Notice of Objection shall specify those items or amounts with which Purchasers
disagree, together with a detailed written explanation of the reasons for disagreement with each
such item or amount, and shall set forth Purchasers&#146; calculation of Closing Working Capital based
on such objections. To the extent not set forth in the Notice of Objection, Purchasers shall be
deemed to have agreed with Sellers&#146; calculation of all other items and amounts contained in the
Closing Working Capital Statement.
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Unless Purchasers deliver a Notice of Objection to Sellers within the Review Period,
Purchasers shall be deemed to have accepted Sellers&#146; calculation of Closing Working Capital and the
Closing Working Capital Statement shall be final, conclusive and binding. If Purchasers deliver a
Notice of Objection to Sellers within the Review Period, Purchasers and Sellers shall, during the
ten (10)&nbsp;days following such delivery or any mutually agreed extension thereof, use their
commercially reasonable efforts to reach agreement on the disputed items and amounts in order to
determine the amount of Closing Working Capital. If, at the end of such period or any mutually
agreed extension thereof, Purchasers and Sellers are unable to resolve their disagreements, they
shall jointly retain and refer their disagreements to an Independent Expert. The parties shall
instruct the Independent Expert promptly to review this <U>Section&nbsp;1.07</U> and to determine
solely with respect to the disputed items and amounts so submitted whether and to what extent, if
any, the Closing Working Capital set forth in the Closing Working Capital Statement requires
adjustment. The Independent Expert shall base its determination solely on written submissions by
Purchasers and Sellers and not on an independent review. Purchasers and Sellers shall make
available to the Independent Expert all relevant Books and Records and other items reasonably
requested by the Independent Expert. The parties shall request that the Independent Expert deliver
to Purchasers and Sellers, as promptly as practicable but in no event later than thirty (30)&nbsp;days
after its retention, a report which sets forth its resolution of the disputed items and amounts and
its calculation of Closing Working Capital; provided that in no event shall Closing Working Capital
as determined by the Independent Expert be more than Sellers&#146; calculation of Closing Working
Capital set forth in the Closing Working Capital Statement nor less than Purchasers&#146; calculation of
Closing Working Capital set forth in the Notice of Objection. The decision of the Independent
Expert shall be final, conclusive and binding on the parties. The costs and expenses of the
Independent Expert shall be allocated between the parties by the Independent Expert based upon the
relative differences between the position asserted by each party and the final resolution of the
disputed items, with the party asserting a position further from the final resolution bearing a
proportionately greater share of such costs and expenses.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.08 <U>Adjustment of Purchase Price</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&#147;<U>Final Working Capital</U>&#148; means the Closing Working Capital (i)&nbsp;as shown in the
Closing Working Capital Statement, if no Notice of Objection with respect thereto is timely
delivered; or (ii)&nbsp;if a Notice of Objection is so delivered, then as agreed by Purchasers and
Sellers pursuant to <U>Section&nbsp;1.07(c)</U> or, in the absence of such agreement, as shown in the
Independent Expert&#146;s calculation. If Final Working Capital is less than $43,362,000, Sellers shall
pay to Purchasers, as an adjustment to the Purchase Price, in the manner and with interest as
provided in <U>Section&nbsp;1.08(b)</U>, an amount of cash equal to the difference between $43,362,000
and Final Working Capital (the &#147;<U>Deficit Amount</U>&#148;). If Final Working Capital exceeds
$43,362,000, Purchasers shall pay to Sellers, in the manner and with interest as provided in
<U>Section&nbsp;1.08(b)</U>, an amount of cash equal to the difference between Final Working Capital
and $43,362,000 (the &#147;<U>Excess Amount</U>&#148;).
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Within five (5)&nbsp;Business Days after Final Working Capital has been finally determined,
(i)&nbsp;if there is a Deficit Amount, Sellers shall pay to Purchasers an amount equal to such Deficit
Amount, together with interest calculated as set forth below, and (ii)&nbsp;if there is an Excess
Amount, Purchasers shall pay to Sellers an amount equal to such Excess Amount, together with
interest calculated as set forth below. Any such payment shall be made by wire transfer of
immediately available funds to one or more accounts as designated in writing by Purchasers or
Sellers, as the case may be. The amount of any payment to be made pursuant to this
<U>Section&nbsp;1.08</U> shall bear interest from and including the Closing Date to but excluding the
date of payment at a rate per annum equal to the Federal Funds Rate in effect from time to time
during the period from the Closing Date to the date of payment. Such interest shall be calculated
daily on the basis of a year of 365&nbsp;days and the actual number of days elapsed, without
compounding.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Any rights accruing to a party under this <U>Section&nbsp;1.08</U> shall be in addition to and
independent of the rights to indemnification under Article&nbsp;IX. Any payments made to any party
under this <U>Section&nbsp;1.08</U> shall not be subject to the terms of Article&nbsp;IX. Any Deficit
Amount owing to Purchasers shall be the joint and several obligation of Sellers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;For all Tax purposes, the parties agree to treat the payment of the Deficit Amount or
Excess Amount, as the case may be, as an adjustment to the Purchase Price except to the extent
applicable Law requires otherwise. The amount of such adjustment shall be allocated between the
Shares of ASI and ASSA in accordance with the principles and in the manner set forth in <U>Section
1.03(a)</U> for the allocation of Purchase Price, taking into account the ASI Working Capital and
the ASSA Working Capital.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE II<BR>
REPRESENTATIONS AND WARRANTIES OF SELLERS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise set forth in a schedule to any particular representation and warranty
(with specific reference to the particular Section of this Agreement to which the information set
forth in such schedule relates; <U>provided</U>, <U>however</U>, that any information set forth
in one schedule shall be deemed to apply to each other schedule thereof to which its relevance is
readily apparent on its face), Sellers hereby jointly and severally represent and warrant to
Purchasers that all of the statements contained in this <U>Article&nbsp;II</U> are true as of the date
of this Agreement (or, if made as of a specified date, as of such date). The inclusion of any
information in a schedule to this Agreement shall not be deemed to be an admission or evidence of
the materiality of such item, nor shall it establish a standard of materiality for any purpose
whatsoever.
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.01 <U>Organization and Authority of Sellers</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;U.S. Seller is a corporation organized, validly existing and in good standing under the
Laws of the State of Illinois. U.S. Seller has all necessary corporate power and authority to
enter into, execute and deliver this Agreement, to carry out its obligations hereunder and to
consummate the transactions contemplated hereby. The execution and delivery of this Agreement by
U.S. Seller, the performance by U.S. Seller of its obligations hereunder and the consummation by
U.S. Seller of the transactions contemplated hereby have been authorized by all requisite corporate
action on the part of U.S. Seller. This Agreement has been executed and delivered by U.S. Seller,
and, assuming due authorization, execution and delivery by Purchasers, this Agreement is a legal,
valid and binding obligation of U.S. Seller, enforceable against it in accordance with its terms,
except as enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium or other
similar laws affecting creditors&#146; rights generally or by the application of general principles of
equity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;International Seller is a <I>soci&#233;t&#233; par actions simplifi&#233;e </I>organized and validly existing
under the Laws of the Republic of France having its registered office at 10 Rue d&#146;Arcueil, BP
90233, 94528 Rungis Cedex, France, and registered with the <I>Registre du Commerce et des Soci&#233;t&#233;s </I>of
Cr&#233;teil under identification number (<I>&#147;num&#233;ro d&#146;identification unique&#148;) </I>602 950 206. Subject to the
provisions of <U>Section&nbsp;11.15</U> hereof, International Seller has all necessary corporate power
and authority to enter into, execute and deliver this Agreement, to carry out its obligations
hereunder and to consummate the transactions contemplated hereby. Subject to the provisions of
<U>Section&nbsp;11.15</U> hereof, the execution and delivery of this Agreement by International Seller,
the performance by International Seller of its obligations hereunder and the consummation by
International Seller of the transactions contemplated hereby have been authorized by all requisite
corporate action on the part of International Seller. When executed and delivered by International
Seller in accordance with <U>Section&nbsp;11.15</U> hereof,
this Agreement will have been executed and delivered by International Seller, and, assuming
due authorization, execution and delivery by Purchasers, this Agreement will be a legal, valid and
binding obligation of International Seller, enforceable against it in accordance with its terms,
except as enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium or other
similar laws affecting creditors&#146; rights generally or by the application of general principles of
equity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.02 <U>Organization, Authority and Qualification of Spine Entities</U>. Each of ASI, ASSA and Spine Next America Corp., a Delaware corporation (&#147;<U>SNAC</U>&#148;)
(collectively, the &#147;<U>Spine Entities</U>&#148;) is a company duly organized and validly existing under
the Laws of the jurisdiction of its incorporation and has all necessary corporate power and
authority to own, operate or lease the properties and assets now owned, operated or leased by it
and to carry on the portion of the Business conducted by such Spine Entity as conducted at the date
of this Agreement. Each Spine Entity is qualified to do business and, in jurisdictions where such
concept is recognized, is in good standing (or its local equivalent) in each jurisdiction in which
the properties leased by it or the
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">operations of the portion of the Business conducted by such
Spine Entity make such qualification necessary or desirable, except to the extent that the failure
to be so qualified or in good standing would not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect. Sellers have made available to Purchasers, through the
Spine Data Room, true, complete and correct copies of the certificate of incorporation and bylaws
or similar organizational documents of the Spine Entities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.03 <U>Capital Stock</U>. <U>Schedule&nbsp;2.03</U> sets forth the authorized, issued and outstanding shares of each of
the Spine Entities, including the identities of the holders of such issued and outstanding shares.
The outstanding shares of ASI and SNAC are duly authorized, validly issued, fully paid and
non-assessable. The outstanding shares of ASSA are duly authorized, validly issued and fully-paid
(&#147;<I>lib&#233;r&#233;es</I>&#148;). There are no outstanding Options with respect to any Spine Entities, and none of the
Spine Entities is subject to any obligation or commitment to issue or grant any Options. There are
no restrictions as to voting rights or disposal of the shares of ASSA or, except to the extent of
any restrictions required by French Law, to the distribution of profits by ASSA. Other than SNAC,
neither ASI nor ASSA holds any equity interests in any other Person. SNAC does not hold any equity
interests in any other Person. Upon consummation of the purchase and sale of the Shares
contemplated by this Agreement, including payment of the Purchase Price, Purchasers shall own the
entire right, title and interest in all outstanding capital stock and equity interests of each of
the Spine Entities, free and clear of all Encumbrances other than Encumbrances created or suffered
to exist by Purchasers, except as such ownership may be limited by: (a)&nbsp;bankruptcy, insolvency,
reorganization, moratorium or other similar laws affecting creditors&#146; rights generally; (b)&nbsp;the
application
of general principles of equity; (c)&nbsp;any facts or circumstances specific to Purchasers; or (d)
any action or omission on the part of Purchasers.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.04 <U>No Conflicts</U> . <U>Schedule&nbsp;2.04</U> sets forth all Consents that are required for the consummation of the
transactions contemplated by this Agreement under any Material Contract, but excluding any Consents
required pursuant to applicable Law or required because of the business of the Purchasers and their
Affiliates or contracts pursuant to which any Purchaser or any Affiliate is a party or by which any
of their respective assets or properties are bound (&#147;<U>Material Consents</U>&#148;). Assuming that
all Material Consents have been obtained and that International Seller has become a party to this
Agreement pursuant to <U>Section&nbsp;11.15</U>, and except as may result from any facts or
circumstances specific to Purchasers or any of their respective Affiliates, the execution, delivery
and performance of this Agreement by the Sellers do not: (a)&nbsp;violate, conflict with or result in
the breach of the certificate of incorporation or bylaws (or similar organizational documents) of
Sellers or the Spine Entities; (b)&nbsp;conflict with or violate any Law or Governmental Order
applicable to Sellers or the Spine Entities, as applicable, or their respective properties; or
(c)&nbsp;violate, conflict with or result in a breach of or default under (with or without notice, lapse
of time or both), any Material Contract or entitle any other party to modify, terminate, cancel,
accelerate or exercise any other right under any Material Contract, except in the case of clauses
(b)&nbsp;and (c), as would not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.05 <U>Governmental Consents and Approvals</U>. The execution, delivery and performance of this Agreement by Sellers do not require any
Consent of any Governmental Authority, except: (a)&nbsp;the requirements of the HSR Act and, to the
extent applicable, the Competition/Investment Laws of any other relevant jurisdiction; (b)&nbsp;any
notification, or where appropriate, consultation, consent or negotiation with a works council,
union, labor board or relevant Governmental Authority concerning the transactions contemplated by
this Agreement; or (c)&nbsp;as may be necessary as a result of any facts or circumstances specific to
Purchasers or any of their respective Affiliates.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.06 <U>Financial Statements</U> .
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Set forth in <U>Schedule&nbsp;2.06(a)</U> are: (a)&nbsp;the unaudited balance sheets and profit and
loss statements for the portion of the Business conducted by ASI for the year ended December&nbsp;31,
2007 and as of and for the six (6)&nbsp;months ended on June&nbsp;30, 2008 (collectively, the &#147;<U>ASI
Financial Statements</U>&#148;); and (b)&nbsp;unaudited balance sheets and profit and loss statements for the
portion of the Business conducted by ASSA for the year ended November&nbsp;30, 2007 and as of and for
the six (6)&nbsp;months ended on May&nbsp;31, 2008
(collectively, the &#147;<U>ASSA Financial Statements</U>&#148; and, together with the ASI Financial
Statements, the &#147;<U>Financial Statements</U>&#148;). Except as set forth in <U>Schedule&nbsp;2.06(a)</U>,
the Financial Statements have been prepared in accordance with GAAP applied on a consistent basis
and fairly present in all material respects the financial condition and results of operations of
the Spine Entities as of the respective dates thereof and for the periods referred to therein.
Since January&nbsp;1, 2007, there has not occurred any material change in accounting methods or
practices or revaluation of assets.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Schedule&nbsp;2.06(b)</U> sets forth all of the items related to the Business that are
included on Seller&#146;s balance sheet, along with Sellers&#146; good faith estimates of the amounts
thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.07 <U>Liabilities</U>. None of the Spine Entities has any Liabilities, except (i)&nbsp;as reflected in the Financial
Statements or as otherwise set forth on <U>Schedule&nbsp;2.06(a), Schedule&nbsp;2.06(b)</U> or <U>Schedule
2.07</U>, (ii)&nbsp;as have been incurred in the ordinary course of business, consistent with past
practice, but not required under GAAP to be reflected in the Financial Statements, (iii)&nbsp;as have
been incurred in the ordinary course of business, consistent with past practice, since the
respective dates of the most recent balance sheets included in the Financial Statements,
(iv)&nbsp;obligations under this Agreement and (v)&nbsp;as included in the calculation of the Final Working
Capital.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.08 <U>Litigation; Insurance Claims</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As of the date hereof, no Action by or against Sellers or any of their Affiliates is
pending or, to the Knowledge of the Sellers, threatened, challenging the legality, validity or
enforceability of this Agreement or the consummation of the transactions contemplated hereby.
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Schedule&nbsp;2.08(b)</U> sets forth (i)&nbsp;the pending Actions (including those involving
Product Claims) as of the date hereof to which any Spine Entity is a party, none of which would,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, and
(ii)&nbsp;each Action (including those involving Product Claims) with respect to which any Spine Entity
has monetary, non-competition or non-solicitation executory obligations arising from the settlement
or other disposition thereof. To the Knowledge of Sellers, no material Action is currently
threatened against any Spine Entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<U>Schedule&nbsp;2.08(c)</U> lists all pending insurance claims under any insurance policy of
any Spine Entity or either Seller with respect to any assets or properties of any Spine Entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.09 <U>Assets; Inventory</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Spine Entities have good and valid title to all tangible assets reflected in the
Financial Statements or that were acquired by such Spine Entities
after the respective dates of such Financial Statements (except those assets that have been
sold or otherwise disposed of since the respective dates thereof in the ordinary course of business
and not in violation of this Agreement), in each case, free and clear of all Encumbrances except:
(i)&nbsp;mechanics&#146;, carriers&#146;, workmen&#146;s, warehouseman&#146;s or other like liens arising or incurred in the
ordinary course of business; (ii)&nbsp;liens for taxes and assessments not yet due and payable or which
are being contested in good faith through appropriate proceedings; (iii)&nbsp;liens incurred or deposits
made in the ordinary course of business in connection with workers&#146; compensation, unemployment
insurance and other types of social security or retirement benefits; (iv)&nbsp;unperfected security
interests retained by sellers of goods to secure the purchase price of such goods to the extent the
obligation to pay such purchase price constitutes a trade account payable; (v)&nbsp;Encumbrances caused
by or resulting from the acts of Purchasers or any of their Affiliates, employees, officers,
directors, agents, contractors, invitees or licensees; and (vi)&nbsp;other Encumbrances, in each case
arising in the ordinary course of business and not incurred or made in connection with the
borrowing of money, provided that such Encumbrances do not, individually or in the aggregate,
materially impair the present use of the encumbered assets (collectively &#147;<U>Permitted
Liens</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Spine Entities do not own any real property and have good and valid title to the
leasehold estates in all real property leased by them (all of such leased real property being
referred to herein as the &#147;<U>Real Property</U>&#148;), free and clear of all Encumbrances, except for
Permitted Liens, easements, reservations, covenants, rights-of-way and other similar restrictions
of record and liens of the other party to the leases thereof arising pursuant to the terms of such
leases. Each Spine Entity enjoys peaceful and undisturbed possession of the Real Property which it
leases (subject to Permitted Liens). <U>Schedule&nbsp;2.09(b)</U> sets forth a list of the address of
all Real Property leased by any Spine Entity as of the date hereof. Sellers have previously
provided or made available to Purchasers through the Spine Data Room true and complete copies of
all Real Property leases. Articles L.145-1 and Articles L.145-4 of the French
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Commercial Code
apply to all leases governed by French law entered into by the Spine Entities, and the Spine
Entities have the right to renew such leases in accordance with Article&nbsp;L.145-8 of the French
Commercial Code. Except for (i)&nbsp;the production of custom instruments and prototypes and (ii)&nbsp;the
assembly and packaging of Products manufactured by Third Parties, none of the Spine Entities
currently manufactures any goods, materials or products at any of the Real Property, nor have they
done so within the past five (5)&nbsp;years at any current or former owned or leased premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except as set forth on <U>Schedule&nbsp;2.09(c)</U>, all inventory of Products held by the
Spine Entities (i)&nbsp;has been designed and manufactured in substantial compliance with applicable
Laws; (ii)&nbsp;is free of material defects in design, materials, fabrication and workmanship; and
(iii)&nbsp;is suitable for use or sale in the ordinary course of business (including remaining available
shelf life for expiry dated Products) and in substantial compliance with applicable Laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.10 <U>Legal Compliance</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;ASI has, and since October&nbsp;14, 2004, ASSA and SNAC have, conducted their respective
businesses, operations and affairs in compliance in all material respects with all Laws and
Governmental Orders applicable thereto, in each case except as set forth on <U>Schedule
2.10(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;No Spine Entity or officer or director thereof has, within the past three (3)&nbsp;years,
(i)&nbsp;been a party to any corporate integrity agreement with the United States Department of Health
and Human Services Office of Inspector General; (ii)&nbsp;had a reporting obligation pursuant to any
settlement agreement entered into with any Governmental Authority; (iii)&nbsp;been, to the Knowledge of
Sellers, under investigation, inquiry or review by any Governmental Authority (or been threatened
with such an investigation, inquiry or review); (iv)&nbsp;received any search warrant, subpoena or civil
investigative demand from any Governmental Authority relating to the Business; (v)&nbsp;been sanctioned
within the meaning of Social Security Act Section&nbsp;1128A or any amendment thereof; (vi)&nbsp;been
convicted of violating (or admitted or been found liable for a violation) the federal False Claims
Act, the federal Anti-Kickback statute, the Health Insurance Portability and Accountability Act of
1996, the federal Civil Money Penalties statute, the federal Stark law, or similar state laws; or
(vii)&nbsp;been debarred, excluded or suspended from participation in any health care program of a
Governmental Authority.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.11 <U>Labor and Employment Matters</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Schedule&nbsp;2.11(a)</U> lists all U.S. Business Employees as of the date hereof and
specifies, with respect to each such Person, the date of hire and title.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;ASI is not a party to any collective bargaining agreement or union contract with, and no
employee of ASI is represented by, any union or other collective bargaining unit. There is no
labor strike, picket, dispute or stoppage pending
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or, to the Knowledge of Sellers, threatened
against ASI, and ASI has not experienced within the past three (3)&nbsp;years any labor strike, picket,
dispute or stoppage or other material labor difficulty involving its employees. To the Knowledge
of Sellers, except to the extent contemplated by French Law, no campaign or other attempt for
recognition has been made by any labor organization or employees with respect to employees of any
Spine Entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except as set forth on <U>Schedule&nbsp;2.11(c)</U>, none of the Spine Entities is engaged in
any unfair labor practice, and there is no unfair labor practice complaint against any Spine Entity
pending or, to the Knowledge of Sellers, threatened before the National Labor Relations Board or
any comparable Governmental Authority.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Each of the Spine Entities has paid in the ordinary course of business all wages and
compensation due to its employees.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;ASI is not a party to any contract or agreement or subject to any Governmental Order that
prevents or restricts its ability to close or relocate any of its facilities or operations. ASI
has not effected a plant closing or mass layoff within the meaning of the Worker Adjustment and
Retraining Notification Act at any of its facilities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.12 <U>Taxes</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each of the Spine Entities has duly filed on a timely basis all material Tax Returns
required to have been filed by it prior to the date hereof. Except as set forth on <U>Schedule
2.12(a)</U>, all of such Tax Returns when filed were true, complete and correct, and each of the
Spine Entities has, within the time and manner prescribed by applicable Laws, paid all Taxes shown
as owing on such Tax Returns. None of the Spine Entities is delinquent in the payment of any Tax.
None of the Spine Entities has requested, or filed any document having the effect of causing, any
extension of time within which to file any material Tax Return that has not since been filed, other
than automatic extensions allowed by Law. None of the Spine Entities has received any written
notice that it is liable or responsible for any Tax deficiencies. Except as set forth on
<U>Schedule&nbsp;2.12(a)</U>, there is no Action or audit currently proposed or threatened in writing,
or pending against or with respect to any of the Spine Entities in respect of any Taxes. There are
no Encumbrances with respect to Taxes upon any of the properties or assets of any of the Spine
Entities (other than Encumbrances for Taxes not yet due). Since November&nbsp;30, 2005, no Taxing
Authority in a jurisdiction where any of the Spine Entities does not file Tax Returns has ever
claimed in writing that a Spine Entity is or may be subject to liability for any Taxes by that
jurisdiction or is required to file a Tax Return in that jurisdiction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;None of the Spine Entities has granted any power of attorney with respect to Taxes that
will continue in effect after Closing.
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->12<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except to the extent that the Spine Entities file a Tax Return on a consolidated basis, or
have entered into a Tax sharing arrangement, with one or more Affiliates, none of the Spine
Entities is obligated to indemnify any other Person with respect to any Taxes. Except to the
extent that the Spine Entities file a Tax Return on a consolidated basis, or have entered into a
Tax sharing arrangement, with one or more Affiliates, none of the Spine Entities is now or has ever
been a party to or bound by any Contract or arrangement (including tax sharing or allocation
agreements) that (i)&nbsp;requires such Spine Entity to make any Tax payment to or for the account of
any other Person, (ii)&nbsp;affords any other Person the benefit of any net operating loss, net capital
loss, investment tax credit, foreign tax credit, charitable deduction or any other credit or Tax
attribute of any of the Spine Entities, or (iii)&nbsp;requires or permits the transfer or assignment of
income, revenues, receipts or gains to any of the Spine Entities from any other Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Each of the Spine Entities has withheld all material Taxes required to have been withheld
in connection with amounts paid or owing to any employee, independent contractor, creditor,
shareholder or other Third Party.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;There is no contract, agreement, plan or arrangement covering any employee or former
employee of any of the Spine Entities that, individually or collectively, would give rise to the
payment of any amount that would not be deductible pursuant to 162(m) of the Code.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;None of the Spine Entities is required to include in income any adjustment pursuant to
Section 481(a) of the Code by reason of a voluntary change in accounting method initiated by any of
the Spine Entities, nor has the Internal Revenue Service proposed any such adjustment or change in
accounting method.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Sellers have made available to Purchasers, through the Spine Data Room, correct and
complete copies of all income Tax Returns for periods ending on or after November&nbsp;30, 2004 and all
examination reports and statements of deficiencies for which a dispute is still pending.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;None of the Spine Entities has waived any statute of limitations in respect of Taxes or
agreed to any extension of time with respect to a Tax assessment or deficiency, other than with
respect to a Tax Return filed on a consolidated basis.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;None of the Spine Entities will be required to include any item of income in, or exclude
any item of deduction from, taxable income for any taxable period (or portion thereof) ending after
the Closing Date as a result of any (i) &#147;closing agreement&#148; as described in Section&nbsp;7121 of the
Code (or any corresponding or similar provision of state, local or foreign income Tax law) executed
on or prior to the Closing Date; (ii)&nbsp;installment sale or open transaction disposition made on or
prior to the Closing Date; or (iii)&nbsp;prepaid amount received on or prior to the Closing Date.
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->13<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.13 <U>Intellectual Property</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Schedule&nbsp;2.13(a)</U> lists all Patents, Trademarks and Copyrights that are owned by
each of the Spine Entities (whether exclusively, jointly with another Person or otherwise)
(collectively, &#147;<U>Owned Intellectual Property&#148;</U>) other than Owned Intellectual Property that
is neither (i)&nbsp;registered (or the subject of an application for registration) nor (ii)&nbsp;material to
the financial condition, properties, assets (including intangible assets), liabilities (including
contingent liabilities), business, operations, results of operations or prospects of the applicable
Spine Entity or the Business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;To the Knowledge of Sellers, no Third Party has an ownership interest in Owned
Intellectual Property other than: (i)&nbsp;such Owned Intellectual Property that is not material to the
financial condition, properties, assets (including intangible assets), liabilities, (including
contingent liabilities), business, operations, results of operations or prospects of the applicable
Spine Entity or the Business; (ii)&nbsp;as referenced on <U>Schedule&nbsp;2.13(b)</U>; and (iii)&nbsp;ownership
rights that may vest in the inventors of the Patents listed on <U>Schedule&nbsp;2.13(a)</U> originating
from ASSA. To the Knowledge of
Sellers, no Seller or Spine Entity has received any written communication from a Third Party
alleging facts that would permit such Third Party to exercise any reversionary ownership rights in
Patents included in the Owned Intellectual Property pursuant to Contracts contained in the Spine
Data Room.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Sellers have made available to Purchasers, through the Spine Data Room, all material
licenses, sublicenses and other agreements pursuant to which a Third Party authorizes any of the
Spine Entities to use or practice any rights under, or grant sublicenses with respect to, any
Patents, Trademarks or Copyrights other than (i)&nbsp;shrink-wrap and similar end user licenses for
mass-marketed, off-the-shelf Software, and (ii)&nbsp;confidentiality and similar agreements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Sellers have made available to Purchasers, through the Spine Data Room, all material
licenses, sublicenses and other agreements pursuant to which any of the Spine Entities authorizes a
Third Party to use or practice any rights under, or grant sublicenses with respect to, any Owned
Intellectual Property, other than confidentiality and similar agreements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;All registration, maintenance and renewal fees related to Registered Patents and
Trademarks that are currently due have been paid and all documents and certificates related to such
property have been filed with the relevant Governmental Authority for the purposes of maintaining
such Registered Patents and Trademarks. &#147;<U>Registered Patents and Trademarks</U>&#148; means the
Patents and Trademarks listed on <U>Schedule&nbsp;2.13(a)</U> that are the subject of an application,
certification, filing or registration of any type by which Intellectual Property Rights are
obtained.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;There are no pending Third Party Actions against any of the Spine Entities seeking: (i)
the nullification of any of the Patents or Trademarks listed on
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->14<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>Schedule&nbsp;2.13(a)</U>; or (ii)
alleging that any Spine Entity or any of its products, services, activities or operations infringes
upon or otherwise unlawfully uses any Intellectual Property Rights of a Third Party. To the
Knowledge of Sellers, no Seller or Spine Entity has received any written communication from a Third
Party alleging that any Spine Entity or any of its products, services, activities or operations
infringes upon such Third Party&#146;s Patents, Trademarks or Copyrights, other than matters disclosed
to Purchasers through the Spine Data Room.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Each of the Spine Entities has taken commercially reasonable steps to protect and preserve
the confidentiality of its Proprietary Information.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.14 <U>Employee Benefits</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Schedule&nbsp;2.14(a)</U> lists each material Plan that any Spine Entity maintains,
contributes to or participates in or has any material liability under. None of the Spine Entities
has any commitment to create any additional Plans.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as set forth in <U>Schedule&nbsp;2.14(b)</U>, neither the execution and delivery of
this Agreement nor the consummation of the transactions contemplated hereby (either alone or upon
the occurrence of any additional acts or events) will result in any material payment (including
severance, unemployment compensation, golden parachute or otherwise) becoming due to any director,
officer, employee, consultant or service provider of or to any Spine Entity under any Plan,
employment agreement or similar employee compensation arrangement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Each of the material defined contribution pension Plans maintained by Sellers or their
respective Affiliates in the United States that is intended to be qualified under Code Section
401(a) has received a determination letter from the Internal Revenue Service that such plan is so
qualified. To the Knowledge of Sellers, nothing has occurred to adversely affect the qualified
status of any such Seller DC Plan, and the Internal Revenue Service has taken no action to revoke
any such determination letter.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;At no time during the period from October&nbsp;13, 2004 to the date hereof, and, to the
Knowledge of Sellers, at no time during the period from the date that is six-years prior to the
date hereof and October&nbsp;13, 2004, has any Spine Entity or any ERISA Affiliate contributed to, been
required to contribute to, or incurred any material withdrawal liability (within the meaning of
Section&nbsp;4021 of ERISA) under, any multiemployer plan (as defined in Section&nbsp;3(37) of ERISA).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;To the Knowledge of Sellers, no written statement regarding a Plan has been made by any
Seller or Spine Entity to any Business Employee (or dependent thereof), or to any participant or
beneficiary under any Plan, that was, in any material respect, not in accordance with such Plan.
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->15<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;In each case, except as would not be material, no payment that is owed or may become due
to any director, officer or employee of any Spine Entity will be non-deductible to Purchasers or
the applicable Spine Entity under Section&nbsp;280G of the Code or be subject to Tax under Section&nbsp;4999
of the Code, nor will Purchasers or any Spine Entity be required to &#147;gross up&#148; or otherwise
compensate any such person because of the imposition of any excise tax on a payment to such person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;As of the Closing (provided that neither Purchaser nor any of its Affiliates adopts a Plan
requiring ASI to provide such benefits or coverage), ASI will not be obligated to provide
post-employment medical benefits or life insurance coverage to any U.S. Business Employee who
retires on or after the Closing Date, except as required by applicable federal or state statutes
requiring the offer of continuation coverage or conversion rights.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.15 <U>Contracts</U>. Except as set forth on <U>Schedule&nbsp;2.15</U>, Sellers have made available to Purchasers,
through the Spine Data Room, all Contracts that are material to the conduct of the Business as
currently conducted and as to which any Spine Entity is a party or by which any of its assets is
bound (collectively, &#147;<U>Material Contracts</U>&#148;). Each Material Contract constitutes the valid
and binding obligation of the applicable Spine Entity and, to the Knowledge of Sellers, of each
other party thereto, except in each case, as may be limited by bankruptcy, insolvency,
reorganization, moratorium or other similar laws affecting creditors&#146; rights or by the application
of general principles of equity. Except as set forth in <U>Schedule&nbsp;2.15</U>, neither the
applicable Spine Entity nor, to the Knowledge of Sellers, any other party thereto is, in any
material respect, in violation of or in default under any Material Contract, nor has there occurred
an event or condition that, with the passage of time or giving of notice (or both), would
constitute a material default under, or permit the termination of, any Material Contract. All
Contracts and arrangements stipulated in article L.225-38 of the French Commercial Code
(&#147;<I>conventions r&#233;glement&#233;es</I>&#148;) to which ASSA was or is a party have been entered into in compliance
with article L.225-38 of the French Commercial Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.16 <U>Operation of Business</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Except for any action or omission on the part of the Sellers in contemplation of executing
this Agreement and consummating the transactions contemplated hereby, since June&nbsp;30, 2008, each
Spine Entity has conducted its business in all material respects in the ordinary course.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Since December&nbsp;31, 2007, to the Knowledge of Sellers, no material customer of any Spine
Entity has indicated in writing to such Spine Entity that it will stop or materially decrease
purchasing Products from such Spine Entity, and, to the Knowledge of Sellers, no material supplier
of any Spine Entity has indicated in writing to such Spine Entity that it will stop or materially
decrease the supply of materials, products or services to such Spine Entity.
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->16<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Assuming all Consents are obtained and other than (x)&nbsp;services provided prior to Closing
by Sellers or their Affiliates (other than the Spine Entities); (y)&nbsp;services to be provided under
the Transition Services Agreement; and (z)&nbsp;services to be provided by any Purchaser or any
Affiliate of any Purchaser after the Closing, each Spine Entity has access to the inventory,
materials, supplies and other tangible assets required to operate its business substantially as of
the date of this Agreement.<U> </U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;To the Knowledge of Sellers, there is no impending Action or Governmental Order that would
preclude the Spine Entities from operating the
Business after the Closing in substantially the same manner as it is being operated
immediately prior to the Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.17 <U>Regulatory Matters</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each Spine Entity has all Registrations required by applicable Laws to operate its
business as conducted as of the date of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Schedule&nbsp;2.17(b)</U> lists each material investigation or inspection to which a Spine
Entity was notified in writing by a Regulatory Authority which, to the Knowledge of Sellers, has
been conducted during the past three (3)&nbsp;years with respect to any Product or any facility or
operation of any Spine Entity. Each Spine Entity has responded accurately and completely to all
requests, observations, notices and warnings of the applicable Regulatory Authority in connection
therewith, and has, to the Knowledge of Sellers, resolved to the satisfaction of the applicable
Regulatory Authority all issues raised by it in connection therewith.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except as set forth in <U>Schedule&nbsp;2.17(c)</U>, all Spine Entities are in substantial
compliance with Regulatory Laws pertaining to adulteration or misbranding of a Product.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Except as set forth in <U>Schedule&nbsp;2.17(d)</U>, no Product has been the subject of a
Field Action, no Field Action is being initiated by any Spine Entity and, to the Knowledge of
Sellers, no Field Action has been requested or ordered by any Governmental Authority, physician, or
consumer group. Since January&nbsp;1, 2006, no Spine Entity has received a warning letter from the FDA
or any equivalent notification from any other Governmental Authority concerning any of its
products, processes or systems or been subject to any seizure, injunction or import/export
restrictions from the FDA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Each Spine Entity is ISO 13485 certified.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.18 <U>Securities Purchase Agreement Matters</U>. Sellers, the Spine Entities and each of their current and former employees, officers,
directors, shareholders or stockholders, Affiliates, agents, attorneys, insurers, managers,
trustees, partners, owners and other representatives, and each of their predecessors, successors
and assigns (collectively, the &#147;<U>Releasees</U>&#148;) have been released, remised, relinquished,
waived,
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->17<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">acquitted and forever discharged of and from any and all claims, demands, actions, causes of
action, damages, costs, expenses and liabilities of every character whatsoever, direct or indirect,
known or unknown, suspected or unsuspected, alleged or not alleged, liquidated or unliquidated,
choate or inchoate, in law, equity or otherwise, including claims for attorney&#146;s fees, principal or
interest, which the parties listed on <U>Schedule&nbsp;2.18</U> ever had or may thereafter have on
account of or in any way arising out of or relating to that certain Securities Purchase Agreement,
dated October&nbsp;13, 2004, including, but not limited to, any alleged obligations or payments
thereunder and/or Sellers&#146; efforts to obtain regulatory approval for the Wallis System, whether
arising under the laws, statutes, or ordinances of any country, state or locality or in contract,
in tort or otherwise. The parties listed on <U>Schedule&nbsp;2.18</U> include all Persons who ever had
or may hereafter have any claim against the Releasees under or pursuant to the Securities Purchase
Agreement, dated October&nbsp;13, 2004.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.19 <U>Spine Data Room</U>. <U>Schedule&nbsp;2.19</U> sets forth a true, complete and correct list of all documents and
information made available by Sellers to Purchasers as of the date hereof through the Merrill
Corporation Data Site administered by Sellers and their advisors in connection with the
transactions contemplated by this Agreement (the &#147;<U>Spine Data Room</U>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.20 <U>Disclaimer</U>. EXCEPT AS SET FORTH IN THIS AGREEMENT, NONE OF THE SELLERS, THEIR RESPECTIVE AFFILIATES OR
ANY OF THEIR RESPECTIVE OFFICERS, DIRECTORS, EMPLOYEES OR REPRESENTATIVES MAKE OR HAVE MADE ANY
OTHER REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, AT LAW OR IN EQUITY, IN RESPECT OF SELLERS,
THE SPINE ENTITIES, THEIR RESPECTIVE AFFILIATES OR THE BUSINESS. ANY SUCH OTHER REPRESENTATION OR
WARRANTY IS HEREBY EXPRESSLY DISCLAIMED.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE III<BR>
REPRESENTATIONS AND WARRANTIES OF PURCHASERS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchasers hereby jointly and severally represent and warrant to Sellers that all of the
statements contained in this <U>Article&nbsp;III</U> are true as of the date of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.01 <U>Organization and Authority of Purchasers</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;U.S. Purchaser is a corporation organized, validly existing and in good standing under the
Laws of the State of Delaware. U.S. Purchaser has all necessary corporate power and authority to enter into, execute and deliver this Agreement, to
carry out its obligations hereunder and to consummate the transactions contemplated hereby. The
execution and delivery of this Agreement by U.S. Purchaser, the performance by U.S. Purchaser of
its obligations hereunder and the consummation by
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->18<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">U.S. Purchaser of the transactions contemplated
hereby have been authorized by all requisite corporate action on the part of U.S. Purchaser. This
Agreement has been executed and delivered by U.S. Purchaser, and, assuming due authorization,
execution and delivery by Sellers, this Agreement is a legal, valid and binding obligation of U.S.
Purchaser, enforceable against it in accordance with its terms, except as enforcement may be
limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting
creditors&#146; rights generally or by the application of general principles of equity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Subject to the provisions of <U>Section&nbsp;4.18</U> hereof, when formed, International
Purchaser will be organized and validly existing under the Laws of the Republic of France. When
International Purchaser becomes a party to this Agreement pursuant to <U>Section&nbsp;4.18</U>,
International Purchaser will have all necessary corporate power and authority to enter into,
execute and deliver this Agreement, to carry out its obligations hereunder and to consummate the
transactions contemplated hereby. Subject to the provisions of <U>Section&nbsp;4.18</U>, the execution
and delivery of this Agreement by International Purchaser, the performance by International
Purchaser of its obligations hereunder and the consummation by International Purchaser of the
transactions contemplated hereby will be authorized by all requisite corporate action on the part
of International Purchaser. When executed and delivered by International Purchaser in accordance
with <U>Section&nbsp;4.18</U>, assuming due authorization, execution and delivery by Sellers, this
Agreement will be a legal, valid and binding obligation of International Purchaser, enforceable
against it in accordance with its terms, except as enforcement may be limited by bankruptcy,
insolvency, reorganization, moratorium or other similar laws affecting creditors&#146; rights generally
or by the application of general principles of equity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.02 <U>No Conflicts</U>. Assuming that all Consents have been obtained and, except as may result from any facts or
circumstances relating to Sellers, Other Sellers or any of their respective Affiliates, the
execution, delivery and performance of this Agreement by the Purchasers do not: (a)&nbsp;violate,
conflict with or result in the breach of the certificate of incorporation or bylaws (or similar
organizational documents) of Purchasers; or (b)&nbsp;conflict with or violate any Law or Governmental
Order applicable to Purchasers, except, in the case of clause (b), as would not, individually or in
the aggregate, materially and adversely affect the ability of Purchasers to carry out their
obligations under, and to consummate the transactions contemplated by, this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.03 <U>Governmental Consents and Approvals </U>. The execution, delivery and performance of this Agreement by Purchasers do not require any
Consent of any Governmental Authority, except: (a)&nbsp;the requirements of the HSR Act and, to the
extent applicable, the Competition/Investment Laws of any other relevant jurisdiction; (b)&nbsp;any
notification, or where appropriate, consultation, consent or negotiation with a works council, union, labor board or relevant
Governmental Authority concerning the transactions contemplated by this Agreement; (c)&nbsp;as may be
necessary as a result of any facts or circumstances specific to Sellers or any of their respective
Affiliates (other than the Spine Entities); or (d)&nbsp;to the extent failure to obtain such Consent
would not prevent
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->19<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or materially delay the consummation by Purchasers of the transactions
contemplated by this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.04 <U>Litigation</U> . As of the date hereof, no Action by or against Purchasers or any of their Affiliates is
pending or, to the knowledge of Purchasers, threatened, challenging the legality, validity or
enforceability of this Agreement or the consummation of the transactions contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.05 <U>Capital Adequacy, Solvency</U>. Each Purchaser represents that immediately after the sale of the Shares and the other
transactions contemplated herein, such Purchaser and each Spine Entity (and any successor
corporation) will have a positive net worth (calculated in accordance with United States generally
accepted accounting principles, consistently applied from period to period and throughout any
period) and will not be insolvent (as defined under the federal Bankruptcy Code (the
&#147;<U>Bankruptcy Code</U>&#148;) and in equity) and that the purchase of the Shares and other
transactions contemplated hereby and any borrowing by such Purchaser or any Spine Entity in
connection with such transactions shall not have the effect of hindering, delaying or defrauding
any creditors of such Purchaser or any Spine Entity (or any successor corporation). Each Purchaser
further represents that: (a)&nbsp;upon consummation of the purchase of the Shares and within the meaning
of Section&nbsp;548 of the Bankruptcy Code, such Purchaser and each Spine Entity (and any successor
corporations) will: (i)&nbsp;have adequate capitalization; (ii)&nbsp;not have an unreasonably small capital
with respect to the business or transactions engaged in or to be engaged in; and (iii)&nbsp;not have
incurred debts that would be beyond the ability of such Purchaser or such Spine Entity (or any
successor corporation) to pay as such debts mature; and (b)&nbsp;the Purchase Price is a reasonably
equivalent value in exchange for the Shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.06 <U>Availability of Funds</U>. Purchasers currently have sufficient immediately available funds in cash or cash
equivalents and will at the Closing have sufficient immediately available funds, in cash, to pay
the Purchase Price and to pay any other amounts payable pursuant to this Agreement and to effect
the transactions contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.07 <U>Representations Acknowledgment</U>. Purchasers acknowledge and agree that only limited personnel of the Sellers were involved
in the negotiation of this Agreement. Purchasers further acknowledge that the representations and
warranties contained in <U>Article&nbsp;II</U> reflect a risk allocation among the parties and no
claims for fraud can be asserted by any Purchaser Indemnitee as a result of any inaccuracy or breach of such representations or warranties other
than intentional inaccuracies or breaches of any such representation or warranty.
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->20<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE IV<BR>
COVENANTS AND AGREEMENTS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.01 <U>Conduct of the Business</U>. From the date of this Agreement until the Closing (or until the earlier termination of this
Agreement in accordance with <U>Section&nbsp;8.01</U>), except: (w)&nbsp;as expressly required by applicable
Law; (x)&nbsp;as set forth on <U>Schedule&nbsp;4.01</U>; (y)&nbsp;as specifically contemplated by or required to
implement this Agreement; or (z)&nbsp;as otherwise waived or consented to in writing by Purchasers,
Sellers shall cause the Spine Entities to:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;carry on the Business in all material respects in the ordinary course of business
consistent with past practice;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;use commercially reasonable efforts to preserve intact the goodwill of the Business and
the relationships of the Spine Entities with their customers, suppliers, distributors, contract
manufacturers and landlords;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;not amend the certificate or articles of incorporation or by-laws (or other comparable
corporate charter documents) of any of the Spine Entities;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;not (i)&nbsp;enter into or modify any employment, severance, termination or similar agreements
or arrangements with any Business Employee, (ii)&nbsp;grant any bonuses, salary increases, severance or
termination pay to, any Business Employee, or (iii)&nbsp;otherwise increase the compensation or benefits
provided to any Business Employee, in each case, other than in the ordinary course of business
consistent with past practice or as may be required by Law;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;not enter into, adopt or amend any Plan with respect to any Business Employees, other than
in the ordinary course of business consistent with past practice or as may be required by Law;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;enter into or modify any Contract with a physician or other health care provider, other
than in the ordinary course of business consistent with past practice;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;not authorize, issue, sell or otherwise dispose of any shares of capital stock of, or any
Option with respect to, any of the Spine Entities;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;not adjust, split, combine, recapitalize or reclassify any of the capital stock of the
Spine Entities;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;except as contemplated by this Agreement, not enter into any agreement, understanding or
arrangement with respect to the sale, voting, registration or repurchase of the capital stock of
the Spine Entities;
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->21<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;not declare, set aside or pay any dividend or other distribution (other than dividends or
other distributions payable solely in cash) in respect of the capital stock of any of the Spine
Entities, or directly or indirectly redeem, repurchase or otherwise acquire, any shares of capital
stock of, or any Option with respect to, any of the Spine Entities;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;pay all accounts payable and other current obligations when they become due and payable in
the ordinary course of business consistent with past practice, except for accounts payable or other
obligations that are the subject of a good faith dispute;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;not create, incur, assume or otherwise become liable for any indebtedness for borrowed
money or capitalized lease obligations, or assume, guarantee, endorse or otherwise as an
accommodation become responsible or liable for the obligations of any other Person, other than in
the ordinary course of business consistent with past practice and other than any intercompany
indebtedness or obligations;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)&nbsp;not incur or commit to any capital expenditures in excess of $250,000 individually or
$500,000 in the aggregate;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)&nbsp;not merge or consolidate with any other Person;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o)&nbsp;not create any subsidiaries;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p)&nbsp;continue to maintain the Books and Records of the Spine Entities on a basis consistent
with past practice;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(q)&nbsp;not change any method or principle of accounting in a manner that is inconsistent with
past practice, except to the extent required by GAAP;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(r)&nbsp;not take any action with respect to any reorganization, liquidation or dissolution of any
of the Spine Entities;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(s)&nbsp;continue to make all material required filings and payments with Governmental Authorities
in connection with the Business consistent with past practice, and use commercially reasonable
efforts to maintain in effect all existing Registrations required for the ongoing operation of the
Business as presently conducted;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(t)&nbsp;maintain all of their material operating assets in the ordinary course consistent with
past practice, normal wear and tear excepted;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(u)&nbsp;not settle any Actions, whether now pending or hereafter made or brought, other than any
settlements which only involve monetary relief that are paid pre-Closing;
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->22<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;not (i)&nbsp;directly or indirectly sell, transfer, lease, pledge, mortgage, encumber or
otherwise dispose of any of its assets, other than in the ordinary course of business consistent
with past practice; (ii)&nbsp;write off, forgive, waive or otherwise cancel, in whole or in part, any
material account receivable, except as required by GAAP or other than in the ordinary course of
business consistent with past practice; (iii)&nbsp;write off, forgive, waive or otherwise cancel, in
whole or in part, any other material Liability, except as required by GAAP or other than in the
ordinary course of business consistent with past practice; (iv)&nbsp;acquire any capital stock or Option
of any other Person; or (v)&nbsp;acquire any material asset or material property of any Person other
than in the ordinary course of business consistent with past practice; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(w)&nbsp;not agree in writing or otherwise to take any of the foregoing actions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.02 <U>Access to Information; Confidentiality</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;From the date hereof until the Closing (or until the earlier termination of this Agreement
in accordance with <U>Section&nbsp;8.01</U>), upon reasonable notice, Sellers shall, and shall cause
the Spine Entities to: (i)&nbsp;afford Purchasers and their Representatives reasonable access to the
properties and Books and Records of the Spine Entities; and (ii)&nbsp;furnish to the Representatives of
Purchasers such additional financial and operating data and other information regarding the
Business (or copies thereof) as they may reasonably request; <U>provided</U>, <U>however</U>,
that any such access or furnishing of information shall be: (x)&nbsp;limited to such access and/or
information as is reasonably required (1)&nbsp;to prepare for the Closing or to prepare for the
separation of the Business and the Spine Entities from the Sellers and integration into the
Purchasers, or (2)&nbsp;to determine the satisfaction of the conditions to Closing contained in
<U>Article&nbsp;VII</U>; <U>provided</U> that Sellers shall have no obligation to afford such access
or furnish such information for the purposes described in this clause (2)&nbsp;or to cause the Spine
Entities to do so following the satisfaction of each of the conditions set forth in <U>Sections
7.01(b)</U> and <U>7.01(d)</U>; and <U>further provided</U>, that Sellers&#146; obligation to afford
such access or furnish such information for the purposes described in this clause (2)&nbsp;or to cause
the Spine Entities to do so shall be limited to information that is contained in documents on hand
and/or documents that are prepared by the Business in the ordinary course of business and to
conversations with the management and legal team of the Business; (y)&nbsp;scheduled and coordinated
through the Person(s) set forth on <U>Schedule&nbsp;4.02 </U>and, in the case of access and/or
information to be provided to any Third Party Representatives of any Purchaser who have not had
access to the Spine Data Room prior to the date hereof, approved in advance by the Person(s) set
forth on <U>Schedule&nbsp;4.02</U>; and (z)&nbsp;conducted at Purchasers&#146; expense, during normal business
hours, under the supervision of U.S. Seller&#146;s or its Affiliates&#146; personnel and in such a manner as
not to interfere with the normal operations of the Business. Sellers shall not be required to
disclose (or cause the Spine Entities to disclose) any information to Purchasers if such disclosure
would be reasonably likely to: (I)&nbsp;cause significant competitive harm to the Business if the
transactions contemplated hereby are not consummated; (II)&nbsp;jeopardize any attorney-client or other
legal privilege; or (III)
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->23<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">contravene any applicable Laws, fiduciary duty or binding agreement
entered into prior to the date hereof. The fact that Purchasers have agreed to limitations on
their access to information in accordance with this <U>Section&nbsp;4.02(a)</U> shall not be construed in any
respect as a waiver of any of the conditions to Closing set forth in <U>Article&nbsp;VII</U>, nor shall
it impose on Purchasers any obligation to grant such a waiver.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The terms of the Confidentiality Agreement, dated as of June&nbsp;5, 2008, between Zimmer
Holdings, Inc. and U.S. Seller (the &#147;<U>Confidentiality Agreement</U>&#148;), shall continue in full
force and effect until the Closing, at which time such Confidentiality Agreement and the
obligations of Purchasers under this <U>Section&nbsp;4.02(b)</U> shall terminate. Each of the
Purchasers agrees to be bound by the terms of the Confidentiality Agreement as if it were a party
to such agreement to the same extent that Zimmer Holdings, Inc. is a party to such agreement.
Notwithstanding the preceding two sentences, for a period of five (5)&nbsp;years from and after the
Closing, except as would have been permitted under the terms of the Confidentiality Agreement and
subject to the provisions of <U>Section&nbsp;11.02</U>, (i)&nbsp;Purchasers and Sellers shall, and shall
cause their respective officers, directors, employees, authorized Representatives and Affiliates
to, treat and hold as confidential, and not disclose to any Person information related to the
discussions and negotiations between the parties regarding this Agreement and the transactions
contemplated hereby; (ii)&nbsp;Purchasers shall, and shall cause their respective officers, directors,
employees, authorized Representatives and Affiliates to, treat and hold as confidential, and not
disclose to any Person any confidential information which was obtained in connection with the
transactions contemplated by this Agreement relating to Sellers (other than confidential
information relating to the Spine Entities and the Business) and their respective Affiliates; and
(iii)&nbsp;Sellers shall, and shall cause their respective officers, directors, employees, authorized
Representatives and Affiliates to, treat and hold as confidential, and not disclose to any Person
any confidential information (A)&nbsp;relating to the Spine Entities or the Business or (B)&nbsp;which was
obtained in connection with the transactions contemplated by this Agreement relating to Purchasers
and their respective Affiliates. If this Agreement is, for any reason, terminated prior to the
Closing, the Confidentiality Agreement shall continue in full force and effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Nothing provided to Purchasers pursuant to <U>Section&nbsp;4.02(a)</U> shall in any way amend
or diminish Purchasers&#146; obligations under the Confidentiality Agreement. Each Purchaser
acknowledges and agrees that any information provided to Purchasers pursuant to <U>Section
4.02(a)</U> or otherwise by or on behalf of the Sellers or any Representative of the Sellers shall
be subject to the terms and conditions of the Confidentiality Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.03 <U>Regulatory and Other Authorizations; Notices and Consents.</U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each of the Sellers and the Purchasers shall use its commercially reasonable efforts to
obtain promptly (and in any case prior to December&nbsp;31, 2008) all Consents of all Governmental
Authorities that may be or become necessary for the performance of its and the
other parties&#146; obligations pursuant to, and the
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->24<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">consummation of the transactions contemplated by, this Agreement.
Sellers and Purchasers shall cooperate in promptly seeking to obtain all such Consents;
<U>provided</U>, <U>however</U>, that Sellers shall not be required to pay any fees or other
payments to any such Governmental Authorities in order to obtain any such Consent (other than
normal filing fees that are imposed by Law on Sellers). Neither the Sellers nor the Purchasers shall
knowingly enter into any acquisition or other agreement, make any announcement with respect to any
transaction or take any other action that could reasonably be expected to have the effect of
materially delaying, impairing or impeding the receipt of any Consents of any Governmental
Authority. Sellers and Purchasers each agree to make, or to cause to be made: (i)&nbsp;an appropriate
filing of a notification and report form pursuant to the HSR Act; and (ii)&nbsp;any other filing or
notification required by any other Competition/Investment Laws, in each case, with respect to the
transactions contemplated by this Agreement within 21&nbsp;days after the date of this Agreement, and to
supply promptly any additional information and documentary material that may be requested pursuant
to the HSR Act or any other Competition/Investment Laws. If any objections are asserted with
respect to the transactions contemplated hereby under any Competition/Investment Law or if any suit
or proceeding is instituted or threatened by any Governmental Authority or any private party
challenging any of the transactions contemplated hereby as violative of any Competition/Investment
Law, each of the Sellers and the Purchasers shall use its commercially reasonable efforts to
promptly resolve such objections.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;To the extent required by applicable Law, each of ASSA and International Seller shall
inform and consult with its respective works council and provide it with all of the required
information regarding the transactions contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Each party to this Agreement shall promptly notify the other parties of any communication
it or any of its Affiliates receives from any Governmental Authority relating to the matters that
are the subject of this Agreement and permit the other parties to review in advance any proposed
communication by such party to any Governmental Authority relating to the matters that are the
subject of this Agreement. Neither the Sellers nor the Purchasers, as applicable, shall agree to
participate in any meeting with any Governmental Authority in respect of any filings, investigation
(including any settlement of the investigation), litigation or other inquiry related to the
transactions contemplated by this Agreement unless it consults with the other parties in advance
and, to the extent permitted by such Governmental Authority, gives the other parties the
opportunity to attend and participate at such meeting. Subject to the Confidentiality Agreement,
the parties to this Agreement shall coordinate and cooperate fully with each other in exchanging
such information and providing such assistance as the other party may reasonably request in
connection with the foregoing and in seeking early termination of any applicable waiting periods
including under the HSR Act and any other applicable Competition/Investment Laws. Subject to the
Confidentiality Agreement, the parties to this Agreement shall provide each other party with copies
of all correspondence, filings or communications between them or any of their Representatives, on
the one hand,
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->25<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and any Governmental Authority or members of its staff, on the other hand, with
respect to this Agreement and the transactions contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.04 <U>Affiliate Transactions</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Immediately prior to the Closing, Sellers shall, and shall cause its Affiliates to,
terminate, effective as of the Closing, all Contracts between the Sellers or any of their
Affiliates (other than the Spine Entities), on the one hand, and any Spine Entity, on the other
hand other than the Transition Services Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Prior to the Closing, all intercompany receivables, payables and loans between Sellers or
any of their Affiliates (other than the Spine Entities), on the one hand, and a Spine Entity, on
the other hand, shall be, at U.S. Seller&#146;s election, settled, paid, capitalized, distributed or
otherwise terminated, with the result that there shall not be intercompany receivables, payables
and loans between Sellers or any of their Affiliates (other than the Spine Entities), on the one
hand, and a Spine Entity, on the other hand, immediately after Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.05 <U>Fulfillment of Conditions</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Sellers shall take all commercially reasonable steps necessary or desirable and proceed
diligently and in good faith to satisfy each condition to the obligations of Purchasers contained
in this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Purchasers shall take all commercially reasonable steps necessary or desirable and proceed
diligently and in good faith to satisfy each condition to the obligations of Sellers contained in
this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.06 <U>Termination of Seller Insurance Coverage</U>. Purchasers acknowledge that all insurance coverage for the Spine Entities under policies of
Sellers and their Affiliates shall terminate as of the Closing and, following the Closing, no
claims may be brought against any policy of Sellers and their respective Affiliates in respect of
the Spine Entities regardless of whether the events underlying such claim arose prior to or after
the Closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.07 <U>Use of Seller Brand</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Except as specifically provided in this <U>Section&nbsp;4.07</U>, from and after the Closing,
Purchasers shall have no right to use the Abbott Name. &#147;<U>Abbott Name</U>&#148; means the mark or
name &#147;Abbott&#148; or any variations and derivatives thereof and any other logos, trademarks, service
marks, names, corporate names, tradenames, slogans and other similar designators of origin of
Sellers or their Affiliates that incorporate, represent or are used in conjunction with such name
or such variations or derivations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Purchasers shall promptly, and in any event within one hundred and twenty (120)&nbsp;days after
the Closing Date, cause the Spine Entities to: (i)
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->26<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">cease to use and remove or cover the Abbott Name
from all signs, billboards, telephone listings, sales invoices, printed forms, documents,
stationery, office supplies or other similar materials, unless such use is required by Law or a
Governmental Authority; and (ii)&nbsp;amend the certificate of incorporation, approval certificate,
business license or other relevant corporate documentation of the Spine Entities to remove any references to the Abbott
Name in the names of the Spine Entities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Purchasers and their Affiliates shall have the right to (i)&nbsp;manufacture, assemble and
package (or have manufactured, assembled and packaged) Products bearing the Abbott Name, to the
same extent as such Products are manufactured, assembled and packaged immediately prior to the
Closing, for up to two (2)&nbsp;years following the Closing Date, (ii)&nbsp;market, promote, sell and
distribute Products, other than instruments, bearing the Abbott Name for up to four (4)&nbsp;years
following the Closing Date, and (iii)&nbsp;furnish Products that are instruments bearing the Abbott Name
to customers for up to eight (8)&nbsp;years following the Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Purchasers and their Affiliates shall use their reasonable best efforts to cause any
Registrations of the Business (other than those addressed in <U>Section&nbsp;4.07(b)</U>) to be revised
to remove any references to the Abbott Name as soon as practicable, but in any event within
twenty-four (24)&nbsp;months following the Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Purchasers may use product literature that bears the Abbott Name for up to twelve (12)
months after the Closing Date. No product literature used after the first anniversary of the
Closing Date may include a reference to the Abbott Name, Sellers or any of their Affiliates,
including any addresses or telephone numbers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Any use by the Purchasers and their Affiliates of the Abbott Name as permitted in this
<U>Section&nbsp;4.07</U> is subject to their use of the Abbott Name in a form and manner, and with
standards of quality, of that in effect for the Abbott Name as of the Closing Date. Purchasers and
their Affiliates shall indemnify and hold harmless Sellers and any of their Affiliates for any
Losses arising from or relating to the use by Purchasers or any of their Affiliates of the Abbott
Name pursuant to this <U>Section&nbsp;4.07</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Each of the parties hereto acknowledges and agrees that the remedy at Law for any breach
of the requirements of this <U>Section&nbsp;4.07</U> would be inadequate, and agrees and consents that
without intending to limit any additional remedies that may be available, Sellers shall be entitled
to a temporary or permanent injunction, without proof of actual damage or inadequacy of legal
remedy, and without posting any bond or other undertaking, in any Action that may be brought to
enforce any of the provisions of this <U>Section&nbsp;4.07</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.08 <U>Credit and Performance Support Obligations</U>. The Purchasers agree to use commercially reasonable efforts to cause Sellers and their
Affiliates (other than the Spine Entities) to be absolutely and unconditionally relieved on or
prior to the Closing of all Liabilities arising out of the letters of credit, performance bonds,
corporate
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->27<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">guarantees and other similar items issued and outstanding in connection with the
Business, and the Purchasers shall indemnify Sellers and their Affiliates (other than the Spine
Entities) against any Losses of any kind whatsoever with respect to such Liabilities. The
Purchasers agree to continue to use commercially reasonable efforts after the Closing to relieve Sellers and their Affiliates
(other than the Spine Entities) of all such Liabilities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.09 <U>Mixed Contracts</U>. Purchasers shall use commercially reasonable efforts to release Sellers and their
Affiliates (other than the Spine Entities) from Liabilities under any customer or vendor Contract
that inures to the benefit or burden of each of the Business and other businesses of the Sellers (a
&#147;<U>Mixed Contract</U>&#148;) to the extent such Mixed Contract relates to the Business or the Products
of the Business. Without limiting the foregoing, Purchasers shall make a bona fide written offer
to the applicable counterparty to each such Mixed Contract to enter into a new Contract regarding
the subject matter of such Mixed Contract as it relates to the Business on commercially reasonable
terms. Sellers agree to cooperate reasonably in all such efforts.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.10 <U>Consultation with Business Employees&#146; Representatives</U>. The Sellers and the Purchasers shall cooperate in connection with any required notification
to, or any required consultation with, the Business Employees, representatives of the Business
Employees, works councils, unions, labor boards and relevant government agencies concerning the
transactions contemplated hereby with respect to the employees of the Spine Entities. Prior to the
Closing Date, all communications between the Purchasers and any group of Business Employees shall
be coordinated with the Person(s) set forth on <U>Schedule&nbsp;4.02</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.11 <U>Transition Services Agreement</U>. At the Closing, Purchasers, the Spine Entities and Sellers shall enter into a Transition
Services Agreement substantially in the form of <U>Exhibit&nbsp;A</U> hereto (the &#147;<U>Transition
Services Agreement</U>&#148;), subject to the completion of the applicable schedules, exhibits and
attachments, if and to the extent referenced therein. Purchasers and Sellers shall cooperate in
good faith to complete such schedules, exhibits and attachments as soon as practicable after the
date hereof, but in any event no later than the Closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.12 <U>Contact with Customers and Suppliers</U>. Until the Closing Date, none of Purchasers, its Affiliates and their Representatives shall
contact or communicate with the customers, suppliers, distributors and licensors of the Business in
connection with the transactions contemplated hereby without the prior written consent of U.S.
Seller, and any such contacts or communications shall be coordinated with the Person(s) set forth
on <U>Schedule&nbsp;4.02</U>. Nothing in this <U>Section&nbsp;4.12</U> shall prohibit Purchasers from
contacting the customers, suppliers and licensors of the Business in the ordinary course of
Purchasers&#146; businesses for the purpose of selling products of the Purchasers&#146; businesses or for any
other purpose unrelated to the Business and the transactions contemplated by this Agreement.
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->28<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.13 <U>Distribution of Cash Balances</U>. Prior to the Closing, Sellers shall be permitted to cause the Spine Entities to distribute
any and all cash balances held by the Spine Entities as directed by Sellers.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.14 <U>Due Diligence; Reliance on Experts</U>. Purchasers acknowledge that they have conducted such due diligence activities and
investigations in connection with the transactions contemplated hereby as Purchasers deem
reasonable or necessary and, in connection with such activities and investigations, Purchasers have
relied on their own financial, legal and other experts and advisors in arriving at their decision
to execute, deliver and consummate this Agreement and the transactions contemplated hereby.
Purchasers are not relying on any representations, warranties or covenants of Sellers (including
any projections, or information contained in the summary business description, management
presentation or other due diligence materials made available to Purchasers) except as expressly set
forth in this Agreement and any certificate or other document executed and delivered to any
Purchaser pursuant to this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.15 <U>Assets and Liabilities Not Held by Spine Entities</U>. To the extent that there are assets or liabilities that are exclusively related to the
Business but that are not held by one of the Spine Entities, U.S. Seller shall transfer or cause
such assets and liabilities to be transferred to one of the Spine Entities prior to the Closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.16 <U>Further Assurances; Post-Closing Cooperation</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each of the Sellers and Purchasers shall use commercially reasonable efforts to take, or
cause to be taken, all appropriate action, to do or cause to be done all things necessary, proper
or advisable under applicable Law, and to execute and deliver such documents and other papers and
any other agreements, as may be necessary to carry out the provisions of this Agreement and
consummate the transactions contemplated by this Agreement, including obtaining all required
Consents from Third Parties, <U>provided</U>, that Sellers shall not be required to pay any fees
or other payments or agree to be responsible for the Business or its obligations following the
Closing in order to obtain any such Consents.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Subject to the terms and conditions of this Agreement, at any time or from time to time
after the Closing, each of the parties hereto shall execute and deliver such other documents and
instruments, provide such materials and information and take such other actions as may reasonably
be necessary, proper or advisable, to the extent permitted by Law, to fulfill its obligations under
this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Following the Closing, Sellers, on the one hand, and Purchasers, on the other hand, shall
afford the other, their counsel and accountants, during normal business hours, reasonable access to
the Books and Records relating to the Business or the Spine Entities in their possession with
respect to periods prior to the Closing and the right to make copies and extracts therefrom, to the
extent that such access may be reasonably required by the requesting party.
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->29<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.17 <U>Transaction Costs</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Whether or not the transactions contemplated hereby are consummated, and except as
otherwise specified herein, Sellers shall bear their own expenses with respect to the transactions
contemplated by this Agreement, including being solely responsible for the fees and expenses of (i)
any broker, finder or investment banker entitled to any brokerage, finder&#146;s or other fee or
commission in connection with the transactions contemplated by this Agreement based upon
arrangements made by or on behalf of either Seller, and (ii)&nbsp;all attorneys, accountants,
consultants and other professionals engaged by any Seller or Spine Entity in connection with the
transactions contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Whether or not the transactions contemplated hereby are consummated, and except as
otherwise specified herein, Purchasers shall bear their own expenses with respect to the
transactions contemplated by this Agreement, including being solely responsible for the fees and
expenses of (i)&nbsp;any broker, finder or investment banker entitled to any brokerage, finder&#146;s or
other fee or commission in connection with the transactions contemplated by this Agreement based
upon arrangements made by or on behalf of either Purchaser, and (ii)&nbsp;all attorneys, accountants,
consultants and other professionals engaged by Purchasers in connection with the transactions
contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.18 <U>International Purchaser</U>. Within twenty (20)&nbsp;days after the date of this Agreement, U.S. Purchaser shall organize
International Purchaser under the laws of the Republic of France and shall cause International
Purchaser to execute a copy of this Agreement and become bound by this Agreement. Upon
International Purchaser signing this Agreement and becoming a party to this Agreement,
International Purchaser shall be entitled to all and any rights, benefits and remedies, and shall
be bound by all the obligations, of any nature whatsoever under, or by reason of, this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.19 <U>Enovia Software</U>. Sellers shall use commercially reasonable efforts to assist Purchasers and/or their
Affiliates in securing use of the software licensed by Sellers and/or their Affiliates from
Dassault Systemes (Enovia) (the &#147;Enovia Software&#148;) for use in connection with the Business as the
Enovia Software is used in the Business as of the date hereof. Such efforts shall include, to the
extent requested by Purchasers, (a)&nbsp;granting permissions and/or licenses to any trade secrets or
other intellectual property rights of Sellers and/or their Affiliates in the configuration of the Enovia Software, and all related
data formats and reports, used by the Business, (b)&nbsp;transferring data exclusively related to the
Business to servers of Purchasers and/or their Affiliates, and (c)&nbsp;authorizing Dassault Systemes or
others to assist Purchasers in configuring and deploying the Enovia Software in the same manner in
which it is configured and deployed by Sellers and/or their Affiliates for use by the Business as
of the date hereof and/or the Closing Date. Purchasers understand that: (i)&nbsp;Purchasers shall be
responsible for securing and paying for any required licenses to the Enovia Software application
other than those referred to in clause (a)&nbsp;above; (ii)&nbsp;Purchasers shall be
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->30<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">responsible for
providing and paying for the resources necessary to configure, deploy or otherwise implement the
Enovia Software; and (iii)&nbsp;the activities contemplated by this Section&nbsp;4.19 shall be conducted in
such a manner so as not to interfere with the normal operations of Sellers and their Affiliates.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE V<BR>
EMPLOYEE MATTERS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.01 <U>Employee Benefit Matters</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Employment</U>. As of the Closing, Purchasers shall cause the Spine Entities to
continue to employ each of the Business Employees in each case in the same position and on
substantially the same terms and conditions (including wages and incentive compensation
opportunity) as provided by the applicable Spine Entity for such Business Employee immediately
prior to the Closing. Purchasers agree that they shall not, nor shall they cause ASSA to, relocate
the Non-U.S. Business Employees during the two-year period following the Closing Date to a work
location more than 20 km from the location at which such employees are employed immediately prior
to the Closing. Except as required by Law, nothing contained in this Agreement shall be construed
as requiring Purchasers or one of their respective Affiliates to continue the employment of any
specific person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Compensation and Benefits Comparability</U>. Immediately following the Closing and
continuing until December&nbsp;31, 2009, Purchasers shall or shall cause their respective Affiliates to
provide to the Business Employees who remain in the employment of Purchasers or any of their
respective Affiliates:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) in the case of U.S. Business Employees, (x)&nbsp;base salary or wage rates and
other cash compensation (other than equity compensation and incentive
compensation) that, in the aggregate, are not less than the base salary or wage
rates and other cash compensation in effect for each such U.S. Business Employee
immediately prior to Closing; and (y)&nbsp;employee benefits, including equity
compensation and incentive compensation, that are comparable to those made
available by U.S. Purchaser to its similarly situated employees; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) in the case of Non-U.S. Business Employees, (x)&nbsp;base salary or wage
rates, equity compensation and incentive compensation and other cash compensation,
and (y)&nbsp;employee benefits (including supplementary pension Plan, complementary
pension Plan, medical, dental and vision insurance, basic and supplemental life
insurance, short and long-term disability insurance, mandatory profit sharing
scheme, voluntary profit sharing scheme, employee savings Plan
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->31<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">and all and any
other employee benefits paid or provided to Non-U.S. Business Employees
immediately prior to the Closing in accordance with the policies of ASSA or any of
its Affiliates such as tuition assistance, adoption assistance, childcare
assistance, management car Plan and transportation allowance) that, on an
individual basis, are of economically similar value to those paid or provided to
each such Non-U.S. Business Employee by ASSA or any of its Affiliates immediately
prior to the Closing. Except as required by Law or as otherwise provided in this
Article&nbsp;V, nothing contained in this Agreement shall be construed as requiring
Purchasers or one of their respective Affiliates to continue any specific Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<U>Severance Benefits and Liabilities</U>. Immediately following the Closing and
continuing until December&nbsp;31, 2009, Purchasers shall or shall cause their respective Affiliates to
provide to the Business Employees severance benefits that are no less favorable on an individual
basis than the severance benefits that would have been applicable to each such Business Employee
under the applicable Spine Entity&#146;s severance Plans or individual agreements, as the case may be,
immediately prior to the Closing, taking into account each such Business Employee&#146;s additional
period of service and rate of base pay or wages and bonus target with Purchasers or their
Affiliates following the Closing. Purchasers and their respective Affiliates shall be solely
responsible for any severance, change in control, redundancy or similar termination payments or
benefits that may become payable to any Business Employee in connection with the transactions
contemplated by this Agreement, and Purchasers shall jointly and severally indemnify Sellers and
their respective Affiliates from any and all Liabilities for such payments and benefits. To the
extent that Sellers or any of their respective Affiliates become liable for, or are legally
required to make, severance, change in control, redundancy or similar termination payments or
benefits to any Business Employee in connection with the transactions contemplated by this
Agreement, Purchasers shall, or shall cause their respective Affiliates to, reimburse Sellers, as
soon as practicable but in any event within thirty (30)&nbsp;days of receipt from Sellers of appropriate
verification, for all payments, costs and expenses actually paid by Sellers or their respective
Affiliates as required by applicable Law or any Contract.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<U>Service Credit</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Except as provided in subsection 5.01(d)(ii), Purchasers shall, and shall
cause their Affiliates to, recognize the prior service, compensation and seniority
of, or recognized with respect to, each Business Employee as if such service had
been performed with, and such compensation and seniority had been earned with, Purchasers for all purposes,
including eligibility, vesting, service related level of benefits and benefit
accrual under the employee benefit Plans and policies provided by Purchasers to
the Business Employees following the Closing (but excluding in the case of U.S.
Business Employees benefit accruals
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->32<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">under any defined benefit pension plans), to
the same extent such service, compensation and seniority is recognized by Sellers
or their Affiliates immediately prior to the Closing, except to the extent that
such recognition would result in a duplication of benefits.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Purchasers shall not be required to, and shall not be required to cause
their Affiliates to, recognize the prior service, compensation and seniority of,
or recognized with respect to, any U.S. Business Employee as if such service had
been performed with, and such compensation and seniority had been earned with
Purchaser for the following purposes: (x)&nbsp;eligibility for participation or benefit
accrual under the Zimmer Retirement Income Plan and/or the Zimmer Benefit
Equalization Plan for the Retirement Income Plan; or (y)&nbsp;eligibility for
participation or benefit accrual under the Zimmer Retiree Medical and Life
Insurance Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;<U>Welfare Plans</U>. With respect to any welfare Plan maintained by Purchasers or any
of their respective Affiliates in which Business Employees are eligible to participate after the
Closing, Purchasers shall, and shall cause their respective Affiliates to: (i)&nbsp;waive all
limitations as to preexisting conditions and exclusions with respect to participation and coverage
requirements applicable to such Business Employees and his or her covered spouse and/or dependents
to the extent such conditions and exclusions were satisfied or did not apply to such Business
Employees under the analogous welfare Plans maintained by Sellers or any of their respective
Affiliates immediately prior to the Closing; and (ii)&nbsp;provide each Business Employee with credit
for any co-insurance, deductibles and accumulations toward out-of-pocket maximums paid by such
Business Employee and his or her covered spouse and/or dependents prior to Closing in the Plan year
in which the Closing occurs under the group health care Plans maintained by Sellers or any of their
respective Affiliates in satisfying any analogous deductible or out-of-pocket requirements to the
extent applicable under any such group health care Plan maintained by Purchasers or any of their
respective Affiliates; provided, however, that no such credit shall affect the applicable limits
under any such welfare Plan maintained by Purchasers or any of their respective Affiliates or
entitle any Business Employee (or covered spouse or dependent) to any refund because such credit
exceeds any limit imposed by Purchasers&#146; Plan. Sellers shall, at their sole cost and expense,
provide Purchasers&#146; group health plan with a report setting forth all co-insurance, deductibles and
accumulations toward out-of-pocket maximums paid by the Business Employees under any such Plan of
Sellers or any of their respective Affiliates as of the Closing Date and as of the date six (6)
months following the Closing Date. Effective as of the Closing, Purchasers or their respective
Affiliates shall assume all obligations for providing coverage under the Consolidated Omnibus
Budget Reconciliation Act of 1985, as amended, to U.S. Business Employees (and their eligible
dependents). Notwithstanding the foregoing, Sellers shall retain responsibility under the Seller welfare
Plans in which the Business Employees participate with respect to all welfare benefit claims
incurred by the Business Employees and their eligible dependents prior to the
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->33<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Closing, expressly
excluding disability claims. For purposes of the preceding sentence, (i)&nbsp;a welfare benefit claim
under a group health plan shall be considered incurred on the date when the services are rendered
or supplies are provided and not when the condition arose or when the course of treatment began,
(ii)&nbsp;a welfare benefit claim under a life insurance benefit plan shall be considered incurred on
the date of death and (iii)&nbsp;a claim for workers&#146; compensation shall not be considered and is not a
welfare benefit claim.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;<U>Flexible Spending Account</U>. Effective as of the Closing, Purchaser and its
Affiliates shall have in effect flexible spending reimbursement accounts under a cafeteria Plan
qualifying under Section&nbsp;125 of the Code (the &#147;<U>Purchaser FSA Plans</U>&#148;). Purchaser shall
cause the Purchaser FSA Plans to accept a spin-off of the flexible spending reimbursement accounts
of each Business Employee who participates in the cafeteria Plans maintained by Sellers or their
respective Affiliates (the &#147;<U>Seller FSA Plans</U>&#148;) immediately prior to the Closing and to
honor and continue through December&nbsp;31 of the year in which the Closing occurs the elections made
by each Business Employee under the Seller FSA Plans in respect of such flexible spending
reimbursement accounts that are in effect immediately prior to the Closing. As soon as practicable
following the Closing, Sellers or their respective Affiliates shall cause to be transferred from
the Seller FSA Plans to the Purchaser FSA Plans the excess, if any, of the aggregate accumulated
contributions to the flexible spending reimbursement accounts made by Business Employees prior to
the Closing during the year in which the Closing occurs over the aggregate reimbursement payouts
paid or payable to the Business Employees for such year from such accounts. From and after the
Closing, Purchaser shall assume and be solely responsible for all claims by Business Employees
under the Seller FSA Plans incurred at any time during the calendar year in which the Closing
occurs, whether incurred prior to, on or after the Closing, that have not been paid in full as of
the Closing. If the Closing occurs after December&nbsp;31, 2008, Sellers or their respective Affiliates
shall maintain and continue to process claims related to the 2008 Plan year for such Seller FSA
Plans.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;<U>U.S. Defined Benefit Pension Plans</U>. As of the Closing: (i)&nbsp;U.S. Business
Employees who do not, as of the Closing, have an accrued benefit under the defined benefit pension
Plans maintained by U.S. Seller or its Affiliates in the United States (collectively, the &#147;<U>U.S.
Seller Pension Plans</U>&#148;) shall cease to be eligible to accrue benefits in the U.S. Seller Pension
Plans; and (ii)&nbsp;U.S. Business Employees who, as of the Closing, have an accrued benefit under the
U.S. Seller Pension Plans shall cease to accrue additional benefits and their accrued benefits
shall be frozen under the U.S. Seller Pension Plans.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;<U>Defined Contribution Plans</U>. Effective as of the Closing, Purchasers shall
establish or designate defined contribution pension Plans (collectively, the &#147;<U>Purchaser DC
Plans</U>&#148;) for the benefit of the Business Employees who participated in one or more of the
defined contribution pension Plans maintained by Sellers or their respective Affiliates in the
United States that are intended to be qualified under Code Section 401(a) immediately prior to the Closing (the &#147;<U>Seller DC Plans</U>&#148;). Such
Business
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->34<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Employees are referred to hereinafter as the &#147;<U>DC Employees</U>&#148;. Sellers shall cause
Seller DC Plans to fully vest the account balances of all DC Employees. Each Purchaser DC Plan
shall provide for the receipt from DC Employees of &#147;eligible rollover distributions&#148; (as such term
is defined under Section&nbsp;402 of the Code) in cash and promissory notes evidencing outstanding loans
to DC Employees, which shall be transferred in-kind. Purchaser agrees to take all actions
necessary to cause the Purchaser DC Plans to accept such eligible rollover distributions. As soon
as practicable following the Closing Date, Purchasers shall provide Sellers, and Sellers shall
provide Purchasers, a favorable determination letter from the Internal Revenue Service stating that
the Purchaser DC Plans in the case of the Purchasers, and the Seller DC Plans in the case of the
Sellers, are qualified under Code Section&nbsp;401(a). Each DC Employee shall be given the opportunity
to receive a distribution of his or her account balance under any Seller DC Plan and shall be given
the opportunity to elect to &#147;roll over&#148; such account balance, including outstanding Plan loan
obligations in-kind, to a Purchaser DC Plan, subject to and in accordance with the provisions of
such plan(s) and applicable Law, provided that such &#147;rollover&#148; of outstanding Plan loan obligations
shall occur as soon as administratively practicable, but it no event later than ninety (90)&nbsp;days
following the Closing. Purchasers and Sellers shall work together in order to facilitate any such
distribution or rollover and to effect an eligible rollover distribution for those DC Employees who
elect to rollover their account balances and outstanding Plan loan obligations directly into a
Purchaser DC Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;<U>Nonqualified Deferred Compensation</U>. Effective as of the Closing, Purchasers shall
make available deferred compensation (defined contribution) arrangements that are not intended to
be qualified under Section 401(a) of the Code to the Business Employees who participated in one or
more of the deferred compensation (defined contribution) arrangements maintained in the United
States that are not intended to be qualified under Section 401(a) of the Code maintained by Sellers
or their respective Affiliates (the &#147;<U>Seller NQ Plans</U>&#148;) with respect to the service of such
Business Employees following the Closing. As of the Closing, Sellers and their respective
Affiliates shall retain all Liabilities and obligations for all accrued obligations attributable to
the Business Employees under each Seller NQ Plan. Purchasers and their respective Affiliates shall
provide to Sellers and their respective Affiliates any and all records and information with respect
to the Business Employees reasonably required by Sellers and their respective Affiliates to enable
Sellers and their respective Affiliates to properly administer the Seller NQ Plans following the
Closing. Such provision of records and information shall occur (a)&nbsp;on each anniversary of the
Closing Date or (b)&nbsp;with respect to records and information relevant to the Business Employees&#146;
separation from service within the meaning of Section&nbsp;409A of the Code, within thirty (30)&nbsp;days
following the occurrence of such separation from service. Notwithstanding anything in this
Agreement to the contrary, Sellers and their respective Affiliates shall have the right to
communicate with the Business Employees following the Closing with respect to the accrued
obligations attributable to the Business Employees under each Seller NQ Plan (including with
respect to the amount of such accrued obligations, the Business Employees&#146; rights to receive a
distribution of such accrued obligations, and the Business Employees&#146; elections
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->35<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">with respect to
such accrued obligations) or with respect to any other information that Sellers and their respective Affiliates determine, in their sole discretion, to be necessary
for the proper administration of the Seller NQ Plans.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;<U>ESPP</U>. Effective as of the Closing, each Business Employee who participates in an
employee stock purchase Plan maintained by Sellers or their respective Affiliates immediately prior
to the Closing (the &#147;<U>Seller ESPPs</U>&#148;) shall cease participation in the applicable Seller
ESPPs and shall have his or her payroll deductions refunded by Sellers to the extent not yet
invested as soon as administratively practicable in accordance with the terms of the Seller ESPPs.
As of the Closing, Business Employees shall be eligible to participate in the employee stock
purchase plans sponsored by Purchasers in accordance with the terms of such Plans.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;<U>Retiree Welfare Benefits</U>. Purchasers shall have no liability for retiree health
and life insurance coverage for any Business Employee who has retired from the Business prior to
the Closing. Sellers shall not be responsible or otherwise liable for the provision of
post-retirement healthcare and life insurance coverage to any Business Employee who retires on or
after the Closing. Unless due to Purchasers&#146; own actions, Purchasers shall not be required to
offer or provide post retirement healthcare or life insurance to any Business Employee, except as
required by French Law, or for purposes of U.S. Business Employees, except as required by
applicable federal or state statutes requiring the offer of continuation coverage or conversion
rights.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;<U>Treatment of Unvested Options and Restricted Stock Units</U>. With respect to each
outstanding unvested stock option and unvested restricted stock unit held by a Business Employee as
of the Closing that is forfeited by such Business Employee solely due to the Closing, Sellers shall
pay each such Business Employee the following amounts, subject to any required withholding taxes,
as soon as practicable following the effective date of such forfeiture:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) with respect to each such forfeited stock option, an amount equal to the
product of (a)&nbsp;the excess of (1)&nbsp;the closing per share trading price of a U.S.
Seller common share on the Closing Date, over (2)&nbsp;the exercise price of the
forfeited stock option multiplied by (b)&nbsp;the number of U.S. Seller common shares
subject to the forfeited stock option as of the Closing Date; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) with respect to each such forfeited restricted stock unit, an amount
equal to the closing per share trading price of a U.S. Seller common share on the
Closing Date, subject to applicable Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 0%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) <U>Spine Long Term Cash Incentive Plan</U>. As of the Closing, Sellers and their
respective Affiliates shall retain all Liabilities and obligations under the Abbott Spine Division
(SCI)&nbsp;2004 Long Term Cash Incentive Plan (LTCI).
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->36<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)&nbsp;<U>Post-Closing Liabilities</U>. Except to the extent otherwise specifically set forth
in this Section&nbsp;5.01, from and after the Closing, Sellers and their Affiliates shall have no
Liabilities with respect to Business Employees (whether arising or attributable to the period prior to, on or after the Closing), including accrued payroll,
vacation and bonus amounts as of the Closing and including any Liabilities for worker&#146;s
compensation or under any Seller employee benefit Plan, agreement or arrangement, and all Business
Employees shall cease to participate in employee benefit Plans of Sellers and their Affiliates.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.02 <U>Non-Solicitation </U>. Until the second anniversary of the Closing, no Purchaser nor any Affiliate of any
Purchaser shall, directly or indirectly, solicit for employment or employ any employee of Sellers
or their Affiliates with whom Purchasers came into contact in connection with the negotiation of
this Agreement or the related integration and transition matters associated with the transactions
contemplated by this Agreement; <U>provided</U>, <U>however</U>, the foregoing restriction shall
not apply to general solicitations to the public that are not specifically directed to employees of
Sellers or their Affiliates. Until the second anniversary of the Closing, no Seller nor any
Affiliate of any Seller shall, directly or indirectly, solicit for employment or employ any person
who is a Business Employee; <U>provided</U>, <U>however</U>, that the foregoing restriction shall
not apply to general solicitations to the public that are not specifically directed to Business
Employees or to Business Employees who have not been employed by a Spine Entity or an Affiliate of
a Spine Entity for at least ninety (90)&nbsp;days at the time of such solicitation or employment.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE VI<BR>
TAXES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.01 <U>Sellers&#146; Indemnifications</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Sellers shall be liable for, and shall indemnify and hold Purchasers harmless against:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) all Taxes of the Spine Entities payable for any taxable year or taxable
period ending on or before the Closing Date, but excluding the amount of Tax
liability which is included in the calculation of Final Working Capital;
<U>provided</U>, <U>however</U>, that no indemnity shall be provided by Sellers
under this Agreement for Taxes resulting from any transaction undertaken by
Purchasers or any of the Spine Entities after the Closing;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) with respect to any taxable year or taxable period beginning before the
Closing Date and ending after the Closing Date, the portion of the Taxes of the
Spine Entities attributable to the portion of such taxable year or taxable period
ending on the Closing Date,
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->37<!-- /Folio -->
</DIV>





<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">but excluding the amount of Tax liability which is
included in the calculation of Final Working Capital; <U>provided</U>,
<U>however</U>, that no indemnity shall be provided under this Agreement for any
Taxes resulting from any transaction undertaken by Purchasers or any of the Spine
Entities after the Closing;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Taxes imposed on any member (other than any of the Spine Entities) of
any affiliated group with which any of the Spine Entities files or has filed a Tax
Return on a consolidated, combined or unitary basis for a taxable year of such
Spine Entity beginning before the Closing Date and for which any of the Spine
Entities is liable as a result of filing such a Tax Return on a consolidated,
combined or unitary basis, and Taxes of a Seller Affiliate for which any Spine
Entity is liable as a result of a tax sharing agreement with a Seller Affiliate;
and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Losses arising out of a breach of the representations and warranties
contained in Section&nbsp;2.12(c).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;In order to apportion appropriately any income Taxes relating to any taxable year
beginning before (and ending after) the Closing Date, the parties hereto shall apportion such
income Taxes to the taxable period ending on or before the Closing Date by a closing of the books,
consistent with their past practice for reporting items, except that exemptions, allowances or
deductions that are calculated on a time basis, such as the deduction for depreciation, shall be
apportioned on a time basis. In order to apportion appropriately any non-income Taxes relating to
any taxable year beginning before (and ending after) the Closing Date, the parties hereto shall
apportion such non-income Taxes to the taxable period ending on or before the Closing Date as
follows: (i) <I>ad valorem </I>Taxes (including real and personal property Taxes) shall be accrued on a
monthly basis over the period for which such Taxes are levied, or if it cannot be determined over
the period such Taxes are being levied, over the fiscal period of the relevant taxing authority, in
each case irrespective of the lien or assessment date of such Taxes; (ii)&nbsp;all Taxes relating to
actions by the Purchasers or the Spine Entities outside the ordinary course of business occurring
on or after the Closing Date shall be apportioned to the period ending after the Closing Date; and
(iii)&nbsp;franchise and other privilege Taxes not measured by income shall be accrued on a monthly
basis over the period to which the privilege relates.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.02 <U>Purchasers&#146; Indemnification</U>. Except as otherwise provided in this <U>Article
VI</U>, Purchasers shall be liable for, and shall indemnify and hold Sellers harmless from and
against: (i)&nbsp;any and all Taxes imposed on Purchasers or any of the Spine Entities; (ii)&nbsp;any amounts
payable to Sellers under Section&nbsp;6.03; and (iii)&nbsp;any Excess Tax Amount determined under <U>Section
6.08</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.03 <U>Refunds or Credits</U>. Purchasers shall promptly pay to Sellers any refunds or
credits of Taxes (other than any refund or credit taken into account as an asset
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->38<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in determining
Final Working Capital) received by Purchasers or any of the Spine Entities: (a)&nbsp;relating to the
Spine Entities for any taxable year or taxable period or portions of a taxable year (described in
<U>Section&nbsp;6.01(a)(ii)</U>) ending on or before the Closing Date; or (b)&nbsp;attributable to an amount
paid by Sellers. Purchasers shall be entitled to all other refunds and credits of Taxes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.04 <U>Tax Returns</U>. Sellers shall file or cause to be filed when due all Tax Returns
that are required to be filed by or with respect to any of the Spine Entities for taxable years or
taxable periods ending on or before the Closing Date, and shall timely remit all Taxes shown as due
on such Tax Returns. Purchasers shall file or cause to be filed when due all Tax Returns that are
required to be filed by or with respect to any of the Spine Entities for taxable years or taxable
periods ending after the Closing Date, and shall timely remit all Taxes shown due on such Tax
Returns. All Tax Returns required to be filed pursuant to this Section shall be prepared on a
basis consistent with past practices to the extent permitted by applicable Laws. With respect to
any Tax Return required to be filed by Purchasers and as to which any Taxes are allocable to
Sellers under this <U>Article&nbsp;VI</U>, Purchasers shall provide Sellers with a copy of such
completed Tax Return and a statement certifying the amount of Taxes shown on such Tax Return that
is allocable to Sellers pursuant to the principles of this <U>Article&nbsp;VI</U>, together with
appropriate supporting information and schedules, at least twenty (20)&nbsp;days prior to the due date
(including any extension thereof) for the filing of such Tax Return (or in any event as soon as
practicable) and, except as provided in this <U>Section&nbsp;6.04</U>, shall obtain Sellers&#146; express
written consent (which shall not be unreasonably withheld or delayed) to such Tax Return prior to
the filing of such Tax Return; <U>provided</U> that any disputes shall be decided by an
Independent Expert. If the Independent Expert is unable to resolve all disputes with respect to a
Tax Return described in the immediately preceding sentence prior to the due date for filing such
Tax Return (including any extension thereof), such Tax Return shall be handled in the following
manner: (i)&nbsp;Purchasers shall file such Tax Return by the due date; (ii)&nbsp;Purchasers shall pay the
Taxes shown as owing on such Tax Return; (iii)&nbsp;Sellers shall pay to Purchasers the amount of Taxes
apportioned to Sellers except to the extent such Taxes are in dispute; (iv)&nbsp;the Independent Expert
shall resolve the remaining disputes regarding such Tax Return no later than 30&nbsp;days following the
due date for filing such Tax Return (including any extension thereof); and (v)&nbsp;Purchasers shall
file an amended Tax Return consistent with the determination of the Independent Expert as soon as
practicable following such determination. Except as stated in clause&nbsp;(iii) above, in the event
that an Independent Expert is required to resolve a Tax Return pursuant to this Section&nbsp;6.04,
Sellers shall not be required to indemnify Purchasers for any Taxes with respect to such Tax Return
until the Independent Expert has rendered its determination. The cost of the Independent Expert
shall be shared equally by Purchasers and Sellers.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.05 <U>Mutual Cooperation</U>. From and after the Closing, as soon as practicable, but in
any event within fifteen (15)&nbsp;days after either Sellers&#146; or Purchasers&#146; request, as the case may
be, Purchasers shall deliver to Sellers or Sellers shall deliver to Purchasers, as the case may be,
such information and other data, including work papers,
</DIV>



<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->39<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">relating to the Tax Returns and Taxes of
any of the Spine Entities and shall provide such other assistance as may reasonably be requested,
to cause the completion and filing of all Tax Returns or to respond to audits by any taxing
authorities with respect to any Tax Returns or taxable periods or to otherwise enable Sellers or
Purchasers to satisfy their accounting or Tax requirements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.06 <U>Contests</U>. Whenever any Taxing Authority asserts a claim, makes an assessment, or
otherwise disputes the amount of Taxes for which Sellers are liable under this Agreement,
Purchasers shall upon receipt of such assertion, promptly inform Sellers in writing and Sellers
shall have the sole right to control any resulting proceedings and to determine whether and when to
settle any such claim, assessment or dispute to the extent such proceedings or determinations
affect the amount of Taxes for which Sellers may be liable under this Agreement; <U>provided</U>,
<U>however</U>, that, without the written consent of Purchasers, which shall not be unreasonably
withheld, Sellers shall not settle any such claim, assessment or dispute if such settlement would
reasonably be expected to adversely affect the Tax liability of Purchasers under this Agreement or
the Tax liabilities of the Spine Entities for which Sellers are not obligated to indemnify
Purchasers. Whenever any Taxing Authority asserts a claim, makes an assessment or otherwise
disputes the amount of Taxes for which Purchasers are liable under this Agreement, Purchasers shall
have the right to control any resulting proceedings and to determine whether and when to settle any
such claim, assessment or dispute, except to the extent such proceedings affect the amount of Taxes
for which Sellers are liable under this Agreement. Whenever any Taxing Authority asserts a claim,
makes an assessment or otherwise disputes the amount of Taxes for which both Sellers and Purchasers
may be liable: (a)&nbsp;each party may participate in any resulting proceedings; (b)&nbsp;that portion of the
proceedings shall be controlled by that party that would bear the burden of the greater portion of
the sum of the adjustment and any corresponding adjustments that may reasonably be anticipated for
future taxable periods; and (c)&nbsp;Purchasers shall be entitled to take all such action that they deem
necessary or appropriate to protect their confidential information. Sellers shall promptly inform
Purchasers of any notice or claim they receive from any Taxing Authority that relates to Taxes for
which any of the Spine Entities may be liable and provide Purchasers with a copy of all such claims
and notices.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.07 <U>Transfer Taxes</U>. Sellers and Purchasers shall each bear their respective
liability for all sales (including bulk sales), use, value added, documentary, stamp, gross
receipts, registration, transfer conveyance, excise, recording, license and other similar Taxes and
fees (&#147;<U>Transfer Taxes</U>&#148;) arising out of or in connection with or attributable to the
transactions effected pursuant to this Agreement. Any Tax Returns that must be filed in connection
with any Transfer Taxes shall be prepared by the party incurring such Transfer Tax obligation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.08 <U>Section&nbsp;338</U>. Should Purchasers choose to make an election under Section&nbsp;338 of
the Code with respect to ASSA or ASI (each, a &#147;<U>Section&nbsp;338 Election</U>&#148;), Purchasers shall
promptly notify Sellers of their intent to make any such election. Sellers shall execute such
documents as may be required of it in connection with any such
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->40<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">election promptly after such
documents have been provided to Sellers by Purchasers. Sellers will deliver to Purchasers a
computation of the amount of any Taxes (the &#147;<U>Excess Tax Amount</U>&#148;) which may be imposed on
Sellers or their Affiliates as a result of a Section&nbsp;338 Election, such amount being (i)&nbsp;the excess
of the amount of Taxes payable by Sellers or their Affiliates with such Section&nbsp;338 Election having
been made over the amount of Taxes that would have been payable if such Section&nbsp;338 Election had
not been made, plus (ii)&nbsp;the Taxes imposed on Sellers or their Affiliates as a result of the
payments made pursuant to this <U>Section&nbsp;6.08</U> (including the payments described in this
clause (ii)) <U>provided</U> that for purposes of determining the Excess Tax Amount with respect
to an election, the relevant Seller or Seller Affiliate shall be deemed to have paid Taxes in
respect of such an election to the extent that it is required under Law to absorb any Tax attribute
(including, without limitation, foreign tax credits) in excess of the Tax attributes that would
have been absorbed had no such election been made. If Sellers and Purchasers are unable to reach
agreement on the Excess Tax Amount within thirty&nbsp;(30) days following delivery of Sellers&#146;
computation, then the Excess Tax Amount shall be determined by an Independent Expert, who shall
make its determination within thirty&nbsp;(30) days following the date on which it was retained. The
determination of the Independent Expert shall be, absent manifest error, final and binding on
Purchasers and Sellers. Purchasers shall pay the Excess Tax Amount as additional Purchase Price to
Sellers within five&nbsp;(5) Business Days after the determination of the Excess Tax Amount is agreed to
by the parties or determined by the Independent Expert, as the case may be. Purchasers shall also
reimburse Sellers for the expenses incurred in determining such Excess Tax Amount; <U>provided</U>
that the cost of the Independent Expert shall be shared equally by Purchasers and Sellers.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.09 <U>Survival of Obligations and Sole Remedy</U>. The obligations of the parties set
forth in this <U>Article&nbsp;VI</U> shall be unconditional and absolute, and shall remain in effect
until the expiration of the applicable statute of limitations plus ninety (90)&nbsp;days thereafter. To
the extent any indemnification claim arises that is covered by <U>Section&nbsp;6.01 or 6.02</U>, those
Sections shall control the rights and obligations of the parties with respect to such
indemnification claim, and <U>Article&nbsp;IX</U> shall not apply with respect to such claim.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE VII<BR>
CONDITIONS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.01 <U>Conditions to the Obligations of Purchasers</U>. The obligations of Purchasers
hereunder to purchase the Shares are subject to the fulfillment, at or before the Closing, of each
of the following conditions (all or any of which may be waived in whole or in part by Purchasers in
their sole discretion):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Representations, Warranties and Covenants</U>. Each of the representations and
warranties of the Sellers contained in this Agreement and made as of the date of this Agreement
(disregarding all qualifications and exceptions contained
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->41<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">therein relating to materiality or
Material Adverse Effect) shall be true and correct as of the Closing, with the same force and
effect as if made as of the Closing (other than such representations and warranties as are made as
of another date, which shall be true and correct as of such date), except in either case where any
failure of such representations and warranties to be so true and correct would not result in a
Material Adverse Effect. The covenants and agreements contained in this Agreement to be complied
with by the Sellers on or before the Closing shall have been complied with in all material
respects. Purchasers shall have received a certificate signed on behalf of each Seller by an
officer of each Seller to the effect that the conditions set forth in this <U>Section&nbsp;7.01(a)</U>
have been satisfied.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Governmental Approvals</U>. Any waiting period (and any extension thereof) under the
HSR Act applicable to the purchase of the Shares contemplated by this Agreement shall have expired
or shall have been terminated and all Consents required under the Competition/Investment Laws of
Germany or any applicable waiting period thereunder shall have expired or shall have been
terminated.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<U>No Order</U>. No Governmental Authority shall have enacted, issued, promulgated,
enforced or entered any Law or Governmental Order (whether temporary, preliminary or permanent)
that has the effect of making the transactions contemplated by this Agreement illegal or otherwise
prohibiting the consummation of such transactions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<U>International Seller Bound</U>. International Seller shall have signed and become a
party to this Agreement and shall be bound by all the obligations applicable to it hereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;<U>No Material Adverse Effect</U>. Since the date of this Agreement, there shall have
been no event or development that would reasonably be expected to have a Material Adverse Effect
(other than any event or development that is identified on a Schedule to this Agreement).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.02 <U>Conditions to the Obligations of Sellers</U>. The obligations of Sellers hereunder to
sell the Shares are subject to the fulfillment, at or before the Closing, of each of the following
conditions (all or any of which (other than the condition set forth in <U>Section&nbsp;7.02(d)</U>) may
be waived in whole or in part by Sellers in their sole discretion):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Representations, Warranties and Covenants</U>. Each of the representations and
warranties of Purchasers contained in this Agreement made as of the date of this Agreement
(disregarding all qualifications and exceptions contained therein relating to materiality) shall be
true and correct as of the Closing, with the same force and effect as if made as of the Closing
(other than such representations and warranties as are made as of another date, which shall be true
and correct as of such date), except in either case where any failure of such representations and
warranties to be so true and correct would not materially delay or prevent the consummation of the
transactions contemplated
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->42<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">hereby in accordance with the terms hereof. The covenants and agreements
contained in this Agreement to be complied with by Purchasers on or before the Closing shall have
been complied with in all material respects. Sellers shall have received a certificate signed on
behalf of each Purchaser by an officer of each Purchaser to the effect that the conditions set
forth in this <U>Section&nbsp;7.02(a)</U> have been satisfied.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Governmental Approvals</U>. Any waiting period (and any extension thereof) under the
HSR Act applicable to the purchase of the Shares contemplated by this Agreement shall have expired
or shall have been terminated and all Consents required under the Competition/Investment Laws of
Germany shall have been obtained or any applicable waiting period thereunder shall have expired or
shall have been terminated.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<U>No Order</U>. No Governmental Authority shall have enacted, issued, promulgated,
enforced or entered any Law or Governmental Order (whether temporary, preliminary or permanent)
that has the effect of making the transactions contemplated by this Agreement illegal or otherwise
prohibiting the consummation of such transactions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<U>Consultation with the Representatives of the Non-U.S. Business Employees</U>.
International Seller and ASSA shall have each conducted the appropriate consultation with the
representatives of their respective Non-U.S. Business Employees and such consultation shall have
been completed to the reasonable satisfaction of Sellers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;<U>International Purchaser Bound</U>. International Purchaser shall have signed and
become a party to this Agreement and shall be bound by all the obligations applicable to it
hereunder.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE VIII<BR>
TERMINATION
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.01 <U>Termination</U>. This Agreement may be terminated, and the transactions contemplated
hereby may be abandoned:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;at any time before the Closing, by mutual written agreement of Sellers and Purchasers;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;at any time before the Closing, upon written notice, by Sellers or Purchasers to the other
parties hereto, in the event that any Governmental Order or Law in the United States or France
restraining, enjoining or otherwise prohibiting or making illegal the consummation of any of the
transactions contemplated by this Agreement shall have become final and non-appealable;
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->43<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;by either Sellers or Purchasers, upon written notice to the non-terminating parties by the
terminating party, if the Closing shall not have occurred by December&nbsp;31, 2008; <U>provided</U>,
<U>however</U>, that the right to terminate this Agreement under this <U>Section&nbsp;8.01(c)</U>
shall not be available to: (i)&nbsp;the Sellers if any Seller&#146;s failure to fulfill its obligations
under this Agreement shall have been the cause of, or shall have resulted in, the failure of the
Closing to occur on or prior to such date; or (ii)&nbsp;the Purchasers if any Purchaser&#146;s failure to
fulfill its obligations under this Agreement shall have been the cause of, or shall have resulted
in, the failure of the Closing to occur on or prior to such date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.02 <U>Effect of Termination</U>. In the event of termination of this Agreement as provided
in <U>Section&nbsp;8.01</U>, this Agreement shall forthwith become void and there shall be no liability
on the part of any party hereto except: (a)&nbsp;as set forth in <U>Section&nbsp;4.02</U> and <U>Article
XI</U>; and (b)&nbsp;that nothing herein shall relieve any party from liability for any willful breach
of this Agreement occurring prior to such termination, <U>provided</U>, that no party hereto shall
be entitled to recover any special, indirect, incidental, punitive or consequential damages
whatsoever in respect of such breach by the other party, including any claims for damages based on
lost revenues or lost profits, however caused or on any theory.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE IX<BR>
INDEMNIFICATION AND SURVIVAL
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.01 <U>Survival of Representations, Warranties, Covenants and Agreements</U>. The
representations and warranties of Sellers and Purchasers contained in this Agreement shall survive
the Closing for a period of one&nbsp;(1) year from the Closing Date, except that (a)&nbsp;the representations
and warranties (i)&nbsp;contained in <U>Sections&nbsp;2.01, 2.02, 2.03 and 3.01</U> shall survive
indefinitely, (ii)&nbsp;contained in <U>Sections&nbsp;2.10 and 2.17</U> shall survive the Closing for a
period of three (3)&nbsp;years from the Closing Date and (iii)&nbsp;contained in <U>Sections&nbsp;2.12, 2.14(c),
and 2.18</U> shall survive until sixty&nbsp;(60) days after the expiration of the applicable statute of
limitations, and (b)&nbsp;the covenants and agreements of Sellers and Purchasers shall remain in full
force and effect in accordance with their terms; <U>provided</U>, <U>however</U> that any
representation, warranty, covenant or agreement that would otherwise terminate shall continue to
survive, with respect to such claim only, if a Claim Notice or Indemnity Notice (as applicable)
shall have been timely given in good faith based on facts reasonably expected to establish a valid
claim under this <U>Article&nbsp;IX</U> on or prior to such termination date, until the related claim
for indemnification has been satisfied or otherwise resolved as provided in this <U>Article
IX</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.02 <U>Indemnification</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Subject to the provisions of this <U>Article&nbsp;IX</U>, from and after the Closing, Sellers
jointly and severally shall indemnify Purchasers and their respective Affiliates (including the
Spine Entities), officers, directors, agents, successors and assigns (collectively, the
&#147;<U>Purchaser Indemnitees</U>&#148;) in respect of, and hold them harmless from
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->44<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and against, any and
all Losses suffered, incurred or sustained by a Purchaser Indemnitee by reason of or resulting
from:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any breach of representation or warranty or nonfulfillment of or failure
to perform any covenant or agreement on the part of any Seller contained in this
Agreement (other than indemnification claims covered by <U>Section&nbsp;6.01</U>) or
in any closing delivery referred to in <U>Section&nbsp;1.05</U>;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) any claim, demand or Action asserted, brought or instituted by a Third
Party to the extent alleging that any Product infringes the Intellectual Property
Rights of any Person;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) any Product Claim related to a Product sold by any Spine Entity prior
to Closing;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) the Action brought by Comercializadora Mavero, S.A. de C.V. against
U.S.&nbsp;Seller, ASSA and one of their Affiliates relating to the Exclusive
Distribution Agreement entered into on February&nbsp;18, 2002;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) subject to <U>Section&nbsp;9.08</U>, any investigation of the practices or
conduct of the Business or any of the Spine Entities conducted by any Governmental
Authority and any allegations in connection therewith to the extent such
investigation covers the period before the Closing; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) any Action pending against any Spine Entity as of the Closing Date other
than the Action referred to in <U>Section&nbsp;9.02(a)(iv)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Subject to the provisions of this <U>Article&nbsp;IX</U>, from and after the Closing,
Purchasers jointly and severally shall indemnify Sellers and their respective Affiliates, officers,
directors, agents, successors and assigns (collectively, the &#147;<U>Seller Indemnitees</U>&#148;) in
respect of, and hold them harmless from and against, any and all Losses suffered, incurred or
sustained by a Seller Indemnitee by reason of or resulting from any breach of representation or
warranty or nonfulfillment of or failure to perform any covenant or agreement on the part of any
Purchaser contained in this Agreement (other than indemnification claims covered by
<U>Section&nbsp;6.02</U>) or in any closing delivery referred to in <U>Section&nbsp;1.06</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except as set forth in <U>Section&nbsp;9.02(d)</U>, the indemnity obligations of the parties
under <U>Sections&nbsp;9.02(a) and (b)</U> shall be limited as set forth in this <U>Section
9.02(c)</U>.
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->45<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) No indemnity shall be payable under this <U>Article&nbsp;IX</U> with respect
to Losses for which the Indemnified Party has not provided the Indemnifying Party
a timely Claim Notice or timely Indemnity Notice, as applicable, with respect to
such claim, setting forth in reasonable detail the specific facts and
circumstances pertaining thereto as soon as practical following the time at which
the Indemnified Party discovered such claim (except to the extent the Indemnifying
Party is not prejudiced by any delay in the delivery of such notice).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) No indemnity shall be payable under this <U>Article&nbsp;IX</U> until the
aggregate of the Losses suffered, incurred or sustained by the Purchaser
Indemnitees or the Seller Indemnitees, as applicable, exceeds 1% of the Purchase
Price and then, only for Losses in excess of 1% of the Purchase Price.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) An Indemnifying Party shall have no further indemnity obligations under
this <U>Article&nbsp;IX</U> once the aggregate of all Losses paid by it equals 10% of
the Purchase Price.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) An Indemnifying Party&#146;s indemnity obligations under this <U>Article
IX</U> shall be reduced to the extent that the Indemnified Party had a reasonable
opportunity, but failed, in good faith to use commercially reasonable efforts to
recover under a policy of insurance or under a contractual right of set-off or
indemnity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) With respect to indemnification claims described in <U>Section
9.02(a)(ii)</U>:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) no indemnity shall be payable with respect to Losses for which a
Purchaser Indemnitee has not provided a Claim Notice with respect to such claim
setting forth in reasonable detail the specific facts and circumstances pertaining
thereto on or before the second anniversary of the Closing Date, but if such Claim
Notice is provided within that time period, then the rights of the Purchaser
Indemnitees under this <U>Article&nbsp;IX</U> with respect to such claim shall
continue until such claim is fully and finally resolved;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) to the extent such claim relates to Products sold after the Closing Date,
Sellers shall be liable for only 70% of the Losses arising therefrom; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C) to the extent that any Losses are in the nature of royalties (or similar
payments) payable with respect to future sales of one or more Products, the amount
of such Losses shall be equal to the net present value of such royalties based on
the projected sales of such
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->46<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Products, such projected sales (along with the
applicable discount rate and similar factors) to be determined by mutual agreement
of Sellers and Purchasers or, in the absence of such agreement within 45&nbsp;days
following final resolution of such indemnification claim, by an independent Third
Party selected by agreement of Sellers and Purchasers. The costs and expenses of
such independent Third Party, if any, shall be shared equally by Sellers and
Purchasers.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) No indemnity shall be payable pursuant to <U>Section&nbsp;9.02(a)(iii) or
9.02(a)(v)</U> with respect to Losses for which a Purchaser Indemnitee has not
provided a Claim Notice or Indemnity Notice, as applicable, with respect to such
claim, setting forth in reasonable detail the specific facts and circumstances
pertaining thereto on or before the third anniversary of the Closing Date, but if
such Claim Notice or Indemnity Notice is provided within that time period, then
the rights of the Purchaser Indemnitees under this <U>Article&nbsp;IX</U> with respect
to such claim shall continue until such claim is fully and finally resolved.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) Sellers shall have no indemnity obligations for Losses to the extent
such Losses are (A)&nbsp;reflected as Liabilities of a Spine Entity on the balance
sheets included in the Financial Statements, or (B)&nbsp;included in the calculation of
Final Working Capital.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) No Indemnifying Party shall have any indemnity obligations for
consequential, incidental, indirect, special or punitive damages, including any
claims for damages based on lost revenues or profits, however caused or on any
theory; it being understood, however, that this limitation shall not apply to
out-of-pocket Losses paid by any Indemnified Party to a Third Party: (x)&nbsp;pursuant
to a Third Party Claim or (y)&nbsp;as a result of a matter of the type described in
Section&nbsp;9.02(a)(v).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) All &#147;Material Adverse Effect,&#148; &#147;material,&#148; &#147;material adverse&#148; and like
qualifiers contained in the representations and warranties in this Agreement shall
apply in determining whether a representation and warranty has been breached, but
shall not be applied to limit the amount of any indemnifiable Losses resulting
from any such breach.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The limitations on indemnification contained in <U>Section&nbsp;9.02(c)(ii) and (iii)
</U>shall not apply to Losses arising from: (i)&nbsp;breach of the representations, warranties or
covenants contained in <U>Sections&nbsp;2.01</U>, <U>2.02</U>, <U>2.03</U>, <U>2.18</U>,
<U>3.01</U>, <U>3.06</U>, <U>4.02(b)</U>, <U>4.08</U> and <U>4.17;</U> or (ii)&nbsp;claims
described in <U>Section&nbsp;9.02(a)(iv)</U>.
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->47<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Any Liability of the Sellers under this Agreement for indemnification for Losses shall be
determined without duplication of recovery if the state of facts giving rise to such Liability
constituted a breach of more than one representation, warranty, covenant or agreement contained in
this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.03 <U>Indemnity Procedures</U>. All claims for indemnifications by any Indemnified Party
under <U>Section&nbsp;9.02</U> shall be asserted and resolved as set forth in <U>Section&nbsp;9.03</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;In the event any claim or demand in respect of which an Indemnified Party might seek
indemnity under <U>Section&nbsp;9.02</U> is asserted against or sought to be collected from such
Indemnified Party by a Third Party (a &#147;<U>Third Party Claim</U>&#148;), the Indemnified Party shall
promptly deliver a Claim Notice to the Indemnifying Party. The Indemnifying Party shall have the
right, but not the obligation, to control the defense of such Third Party Claim, including the
right, subject to the remaining provisions of this <U>Section&nbsp;9.03(a)</U>, to settle such Third
Party Claim; <U>provided</U> that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) in case any Indemnified Party is a Purchaser Indemnitee, such Indemnified
Party shall have the right to control the defense and settlement of any such Third
Party Claim if the related indemnification claim arises under:
(A)&nbsp;<U>Section&nbsp;9.02(a)(i)</U> based upon a claim of a breach of
<U>Section&nbsp;2.09(c)</U>, <U>Section&nbsp;2.10</U> or <U>Section&nbsp;2.17</U> and, in any
such case, the Third Party Claim relates in whole or in part to the post-Closing
operation of the Business; (B)&nbsp;<U>Section&nbsp;9.02(a)(ii)</U>;
(C)&nbsp;<U>Section&nbsp;9.02(a)(v)</U> if such investigation or allegation covers periods
both before and after the Closing; or (D)&nbsp;<U>Section&nbsp;9.02(a)(iii)</U> or
<U>Section&nbsp;9.02(a)(vi)</U> if, in the reasonable judgment of the Indemnified
Party, all or substantially all of the Losses that would be incurred in connection
with such Third Party Claim would not be indemnifiable by reason of the
limitations set forth in <U>Section&nbsp;9.02(c)(ii)</U> and/or
<U>Section&nbsp;9.02(c)(iii)</U>;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) the Third Party Claim could not reasonably be expected to result in the
Indemnified Party or any Affiliate thereof entering into a consent decree or
becoming subject to injunctive or other non-monetary relief; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) there is no conflict of interest between the Indemnified Party and the
Indemnifying Party with respect to such Third Party Claim; and
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>further, provided</U>, that the limitations on an Indemnifying Party&#146;s right to control the
defense of a Third Party Claim contained in this <U>Section&nbsp;9.03(a)</U> shall not apply with
respect to the matter referenced in <U>Section&nbsp;9.02(a)(iv)</U>.
</DIV>



<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Execution Copy</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->48<!-- /Folio -->
</DIV>





<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">If the Indemnifying Party is entitled to, and elects to exercise its right to, control the defense
and settlement of a Third Party Claim, then: (v)&nbsp;the Indemnifying Party shall diligently defend
such Third Party Claim; (w)&nbsp;the Indemnified Party shall have the right to participate in the
defense and settlement thereof at its own expense; (x)&nbsp;the Indemnified Party shall cooperate with
the Indemnifying Party in the defense and settlement thereof (including providing the Indemnifying
Party with reasonable access to the Books and Records and employees of the Spine Entities in
connection with the matters for which indemnification is sought to the extent the Indemnifying
Party reasonably deems necessary); (y)&nbsp;the Indemnified Party shall not, without the Indemnifying
Party&#146;s prior written consent, admit any liability with respect thereto or enter into any
settlement or compromise thereof; and (z)&nbsp;the Indemnifying Party shall not, without the prior
written consent of the Indemnified Party (which consent shall not be unreasonably withheld,
conditioned or delayed) settle such Third Party Claim unless the sole relief provided in such
settlement is monetary in nature and shall be paid in full by the Indemnifying Party (it being
understood that any amounts that are not indemnifiable by reason of the limitations set forth in
<U>Section&nbsp;9.02(c)</U> shall not be deemed paid by the Indemnifying Party). If the Indemnifying
Party is not entitled to, or declines to exercise its right to, control the defense and settlement
of the Third Party Claim, then: (A)&nbsp;the Indemnified Party shall diligently defend such Third Party
Claim and shall keep the Indemnifying Party fully informed of all settlement discussions, and the
Indemnifying Party shall have the right to participate therein at its own expense; and (B)&nbsp;the
Indemnifying Party shall not be liable for any settlement thereof entered into without its prior
written consent (which consent shall not be unreasonably withheld, conditioned or delayed);
<U>provided</U>, however, that this clause (B)&nbsp;shall not apply to any indemnification claim that
arises under
<font style="white-space: nowrap"><U>Section&nbsp;9.02(a)(v)</U>.</font>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;In the event any Indemnified Party should have a claim under <U>Section&nbsp;9.02</U> against
any Indemnifying Party that does not involve a Third Party Claim, the Indemnified Party shall
promptly deliver an Indemnity Notice to the Indemnifying Party.
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->49<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.04 <U>Adjustment to Purchase Price</U>. Any amounts paid pursuant to this <U>Article
IX</U> or <U>Article&nbsp;VI</U> shall be considered an adjustment to the Purchase Price allocable to
the relevant Spine Entity for Tax purposes to the extent allowed under applicable Law. Purchasers
and Sellers, and each of their respective Affiliates, shall prepare and file, and cause their
Affiliates to prepare and file, Tax Returns consistent with the treatment described in the
foregoing sentence.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.05 <U>Insurance Offset</U>. If the amount of any indemnifiable Losses, at any time
following the payment of an indemnification obligation, is offset or reduced by the payment of any
insurance proceeds, the amount of such insurance proceeds, less any costs, expenses, premiums or
taxes incurred in connection therewith (including but not limited to any future increase in
insurance premiums, retroactive premiums, costs associated with any loss of insurance and
replacement thereof or self-insured component of such insurance coverage) shall be promptly repaid
to the Indemnifying Party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.06 <U>Exclusivity</U>. After the Closing, to the extent permitted by Law and except (a)&nbsp;as
provided in <U>Section&nbsp;1.08</U>, <U>Section&nbsp;4.02</U>, <U>Section&nbsp;4.07</U>, <U>Section&nbsp;4.08</U>,
<U>Section&nbsp;4.16</U>, <U>Section&nbsp;5.02</U> and <U>Section&nbsp;11.09</U> or (b)&nbsp;with respect to claims
for fraud or intentional misrepresentation, the indemnities set forth in this <U>Article&nbsp;IX</U>
and in <U>Article&nbsp;VI</U> shall be the exclusive remedies of Purchasers and Sellers and their
respective officers, directors, employees, agents and Affiliates for any inaccuracy in any
representation or warranty, misrepresentation, breach of warranty or nonfulfillment or failure to
be performed of any covenant or agreement contained in this Agreement. Without limiting the
generality of the foregoing, no party shall have any rights to set off indemnifiable Losses
pursuant to this <U>Article&nbsp;IX</U> and in <U>Article&nbsp;VI</U> against other obligations owed to
another party hereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.07 <U>Preservation of Rights</U>. An Indemnified Party&#146;s rights pursuant to this
<U>Article&nbsp;IX</U> or <U>Article&nbsp;VI</U> shall not be affected by any investigation or knowledge of
the Indemnified Party or by any waiver of any condition by the Indemnified Party. Any
investigation by an Indemnified Party shall be exclusively for its own protection and shall not
impair any right or remedy hereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.08 <U>Government Investigations</U>. In connection with any indemnification claim pursuant
to <U>Section&nbsp;9.02(a)(v)</U>, any Losses relating to investigations or allegations covering
periods both before and after the Closing shall be apportioned pro rata based on the relative
lengths of the pre- and post-Closing periods covered by the investigations and/or allegations. For
example, if an investigation spans a five-year period that includes two years prior to Closing and
three years after Closing, then 40% of the aggregate Losses shall be apportioned to the pre-Closing
period.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE X<BR>
DEFINITIONS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.01 <U>Definitions</U>. As used in this Agreement, the following defined terms have the
meanings indicated below:
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->50<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Abbott Name</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;4.07(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Actions</U>&#148; means any action, suit, proceeding, arbitration or Governmental Authority
investigation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Affiliate</U>&#148; means, with respect to any Person, any other Person directly or indirectly
controlling or controlled by, or under direct or indirect common control with, such Person. For
purposes of this definition, a Person shall be deemed to control another Person if it owns or
controls more than fifty percent (50%) of the voting equity of the other Person (or other
comparable ownership if the Person is not a corporation). As used in this Agreement, the term
&#147;Affiliate&#148; shall, (i)&nbsp;with respect to Sellers, for all periods prior to the Closing, include each
Spine Entity and (ii)&nbsp;with respect to Purchasers, for all periods following the Closing, include
each Spine Entity and any Person Purchasers create to consummate the transactions contemplated by
this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Agreement</U>&#148; means this Stock Purchase Agreement, and the Schedules and Exhibits
hereto, as amended, modified or supplemented from time to time; provided that the Transition
Services Agreement is not a part of this Agreement once it has been executed.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ASI</U>&#148; has the meaning ascribed to it in the recitals of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ASI Financial Statements</U>&#148; has the meaning ascribed to such term in <U>Section
2.06(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ASI Shares</U>&#148; has the meaning ascribed to it in the recitals of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ASSA</U>&#148; has the meaning ascribed to it in the recitals of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ASSA Financial Statements</U>&#148; has the meaning ascribed to such term in <U>Section
2.06(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ASSA Shares</U>&#148; has the meaning ascribed to it in the recitals of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Bankruptcy Code</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;3.05</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Books and Records</U>&#148; means all files, documents, instruments, papers and other books
and records relating to the Business, including financial statements, Tax Returns and related work
papers and letters from accountants, budgets, pricing guidelines, ledgers, journals, deeds, title
policies, minute books, stock certificates and books, stock transfer ledgers, customer lists,
computer files and programs, retrieval programs, operating data and plans and environmental studies
and plans.
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->51<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Business</U>&#148; means solely the researching, developing, selling, marketing or
distributing the Products as such business is conducted by the Spine Entities immediately prior to
the date of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Business Day</U>&#148; means any day that is not a Saturday, a Sunday or other day on which
banks are required or authorized by Law to be closed in the City of Chicago.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Business Employees</U>&#148; means U.S. Business Employees and Non-U.S. Business Employees,
collectively.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Claim Notice</U>&#148; means written notification pursuant to <U>Section&nbsp;9.03</U> of a Third
Party Claim as to which indemnity under <U>Section&nbsp;9.02</U> is sought by an Indemnified Party,
enclosing a copy of all papers served, if any, and specifying the nature of and basis for such
Third Party Claim and for the Indemnified Party&#146;s claim against the Indemnifying Party under
<U>Section&nbsp;9.02</U>, together with the amount or, if not then reasonably determinable, the
estimated amount, determined in good faith, of the Loss arising from such Third Party Claim.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Closing</U>&#148; has the meaning ascribed to such term in <U>Section&nbsp;1.04</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Closing Date</U>&#148; has the meaning ascribed to such term in <U>Section&nbsp;1.04</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Closing Working Capital</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;1.07(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Closing Working Capital Statement</U>&#148; has the meaning ascribed to it in
<U>Section&nbsp;1.07(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Code</U>&#148; means the U.S. Internal Revenue Code of 1986, as amended.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Competition/Investment Law</U>&#148; means any Law that is designed or intended to prohibit,
restrict or regulate: (a)&nbsp;foreign investment; or (b)&nbsp;antitrust, monopolization, restraint of trade
or competition.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Confidentiality Agreement</U>&#148; has the meaning ascribed to such term in <U>Section
4.02(b)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Consent</U>&#148; means any consent, approval, authorization, consultation, waiver, permit,
grant, agreement, certificate, exemption, order, registration, declaration, filing, notice of, with
or to any Person or under any Law, or the expiration or termination of a waiting period under any
Competition/Investment Law, in each case required to permit the consummation of the transactions
contemplated by this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Contract</U>&#148; means any loan or credit agreement, bond, debenture, note, mortgage,
indenture, lease, supply agreement, license agreement, development agreement
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->52<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or other contract, agreement, obligation, commitment or instrument that is legally binding, including all amendments
thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Copyrights</U>&#148; means all copyrights and copyright rights in copyrightable works, and all
applications, registrations and renewals in connection therewith.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>DC Employees</U>&#148; has the meaning ascribed to such term in <U>Section&nbsp;5.01(h)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>DC Transfer Amount</U>&#148; has the meaning ascribed to such term in <U>Section&nbsp;5.01(h)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Deficit Amount</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;1.08(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Encumbrance</U>&#148; means any encumbrance, lien, charge, pledge, mortgage, title retention
agreement, security interest of any nature, adverse claim, exception, reservation, easement, right
of occupation, any matter capable of registration against title, option, right of pre-emption or
privilege or any agreement or other commitment, whether written or oral, to create any of the
foregoing (excluding restrictions on transfer arising under securities Laws).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Enovia Software</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;4.19</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ERISA</U>&#148; means the Employee Retirement Income Security Act of 1974, as amended.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ERISA Affiliate</U>&#148; means any Person who is in the same controlled group of corporations
or who is under common control with a Seller or, before the Closing, the Spine Entities (within the
meaning of Section&nbsp;414 of the Code).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Excess Amount</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;1.08(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Excess Tax Amount</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;6.08</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>FDA</U>&#148; means the United States Food and Drug Administration or any successor thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Federal Funds Rate</U>&#148; means, for a particular day, the offered rate as reported in <I>The
Wall Street Journal </I>published for such day in the &#147;Money Rates&#148; section for reserves traded among
commercial banks for overnight use in amounts of one million dollars or more or, if no such rate is
published for a day, such rate as most-recently published in <I>The Wall Street Journal</I>, calculated on
a daily basis based on a 365-day year.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Field Action</U>&#148; means any correction or removal of a medical device, as defined in 21
C.F.R. part 806 (or analogous Laws of foreign jurisdictions) or similar Laws applicable to Products
not regulated as medical devices.
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->53<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Final Working Capital</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;1.08(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Financial Statements</U>&#148; has the meaning ascribed to such term in <U>Section
2.06(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>GAAP</U>&#148; means United States generally accepted accounting principles consistently
applied from period to period and throughout any period in accordance with the past practices of
U.S. Seller.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Governmental Authority</U>&#148; means any United States federal, state or local or any
non-United States governmental, regulatory or administrative authority, agency or commission or any
court, tribunal, or judicial or arbitral body.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Governmental Order</U>&#148; means any order, writ, judgment, injunction, decree, stipulation,
determination or award entered or issued by or with any Governmental Authority.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>HSR Act</U>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Indemnified Party</U>&#148; means any Person claiming indemnification under any provision of
<U>Article&nbsp;IX</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Indemnifying Party</U>&#148; means any Person against whom a claim for indemnification is
being asserted under any provision of <U>Article&nbsp;IX</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Indemnity Notice</U>&#148; means written notification pursuant to <U>Section&nbsp;9.03(b)</U> of a
claim for indemnity under <U>Article&nbsp;IX</U> by an Indemnified Party, specifying the nature of and
basis for such claim, together with the amount or, if not then reasonably determinable, the
estimated amount, determined in good faith, of the Loss arising from such claim.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Independent Expert</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;1.03(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Industrial Designs</U>&#148; means all rights in features of shape, configuration, pattern,
ornament and the like that are or can be registered as designs or industrial designs under
applicable Laws, and all applications, registrations and renewals in connection therewith.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Intellectual Property</U>&#148; means all registered and unregistered Patents, Copyrights,
Industrial Designs, Proprietary Information, Trademarks and rights in Software, and all
Intellectual Property Rights therein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Intellectual Property Rights</U>&#148; means all forms of legal rights and protections that
pertain to or may be obtained for any type of Intellectual Property under the laws of any
Governmental Authority of any country or jurisdiction.
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->54<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>International Purchaser</U>&#148; has the meaning ascribed to it in the preamble of this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>International Seller</U>&#148; has the meaning ascribed to it in the preamble of this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Knowledge of Sellers</U>&#148; means the actual knowledge of the officers and employees of the
Sellers and Spine Entities listed in <U>Schedule&nbsp;10.01(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Law</U>&#148; means any United States federal, state, local or foreign statute, law,
ordinance, regulation, rule, code, order, other requirement or rule of law, including common law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Liabilities</U>&#148; means any and all debts, liabilities and obligations, whether accrued or
fixed, absolute or contingent, known or unknown, matured or unmatured or determined or
determinable, including those arising under any Law, Action or Governmental Order and those arising
under any Contract, arrangement or undertaking (but excluding any future performance obligations
under any such Contracts, arrangements or undertakings).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Loss</U>&#148; means any and all damages, Liabilities, losses, costs and expenses (including
reasonable attorneys&#146; fees).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Material Adverse Effect</U>&#148; means any change, effect, event, occurrence, state of facts
or development that individually or in the aggregate is materially adverse to the business,
properties, assets, liabilities, financial condition or results of operations of the Business,
taken as a whole; <U>provided</U>, <U>however</U>, that none of the following shall be deemed
(either alone or in combination) to constitute, and none of the following shall be taken into
account in determining whether there has been, a Material Adverse Effect: (a)&nbsp;any adverse change
attributable to the execution of this Agreement, the disclosure or consummation of the transactions
contemplated by this Agreement or the identity of Purchasers or their respective Affiliates as the
purchaser of the Spine Entities; (b)&nbsp;any change, effect, event, occurrence, state of facts or
development: (i)&nbsp;in the financial or securities markets, or economic, regulatory or political
conditions in general; or (ii)&nbsp;in the industries in which the Business operates in general, except
to the extent of any disproportionate effect on the Business; (c)&nbsp;any failure by the Business to
meet any internal or published projections, forecasts or revenue or earnings predictions (but
excluding the causes underlying such failure); (d)&nbsp;changes in Law or GAAP or in the authoritative
interpretations thereof; (e)&nbsp;any action expressly required to be taken pursuant to this Agreement;
or (f)&nbsp;any action or inaction by Purchasers, or approved or consented to in writing by Purchasers,
after the date hereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Material Consents</U>&#148; has the meaning ascribed to such term in <U>Section&nbsp;2.04</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Material Contracts</U>&#148; has the meaning ascribed to such term in <U>Section&nbsp;2.15</U>.
</DIV>






<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->55<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Mixed Contract</U>&#148; has the meaning ascribed to such term in <U>Section&nbsp;4.09</U>.<U>
</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Non-U.S. Business Employee</U>&#148; means any Person who, as of immediately before Closing,
is an employee of ASSA, including in all cases any such employee who is absent from work because of
leave of absence, illness, vacation, holiday or short- or long-term disability.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Notice of Objection</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;1.07(b)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Option</U>&#148; with respect to any Person means any security, right, subscription, warrant,
option, &#147;phantom&#148; stock right or other Contract that gives the right to: (i)&nbsp;purchase or otherwise
receive or be issued any shares of capital stock of such Person or any security of any kind
convertible into or exchangeable or exercisable for any shares of capital stock of such Person; or
(ii)&nbsp;receive or exercise any benefits or rights similar to any rights enjoyed by or accruing to the
holder of shares of capital stock of such Person, including any rights to participate in the equity
or income of such Person or to participate in or direct the election of any directors or officers
of such Person or the manner in which any shares of capital stock of such Person are voted.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Other Sellers</U>&#148; means the Persons set forth on <U>Schedule&nbsp;1.01</U> under the heading
&#147;Other Sellers&#148;.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Owned Intellectual Property</U>&#148; has the meaning ascribed to it in
<U>Section&nbsp;2.13(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Patent</U>&#148; means (a)&nbsp;all patents and patent applications (including provisional
applications and applications for a certificate of invention); (b)&nbsp;all reissues, substitutions,
registrations, re-examinations, additions, continuations, continued prosecution applications,
continuations-in-part, or divisions of, to or for any patent or patent application; and (c)&nbsp;all
term extensions, supplementary protection certificates and other governmental actions that extend
exclusive patent rights to an invention or technology beyond the original patent expiration date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Permitted Liens</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;2.09(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Person</U>&#148; means any individual, corporation, partnership, limited partnership, joint
venture, limited liability company, trust or unincorporated organization or Governmental Authority
or any other entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Plan</U>&#148; means any bonus, incentive compensation, deferred compensation, pension, profit
sharing, retirement, stock purchase, stock option, stock ownership, stock appreciation rights,
phantom stock, leave of absence, layoff, vacation, day or dependent care, legal services,
cafeteria, life, health, accident, disability or other welfare benefit plan, severance or other
employee benefit plan, practice, policy or arrangement, whether written or oral, including any
&#147;employee benefit plan&#148; within the meaning of Section&nbsp;3(3)
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->56<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">of ERISA and excluding workers&#146;
compensation and other employee arrangements required by applicable Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Product Claim</U>&#148; means any Action relating to any actual or alleged personal injury or
property damage arising from any Product, regardless of the specific theory or theories of
liability alleged, including strict liability, negligence, design defect, manufacturing defect,
failure to warn, breach of warranty, or consumer fraud or deception.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Products</U>&#148; means, collectively, the medical device products that have been designed,
developed, manufactured, marketed, distributed or sold by any Spine Entity prior to the Closing
Date and any human bone material distributed or sold by any Spine Entity prior to the Closing Date,
including the products identified on <U>Schedule&nbsp;10.01(b)</U>, but specifically excluding any
pharmaceutical, diagnostic, vascular or nutritional products. For purposes of <U>Section
9.02(a)(ii)</U>, if any next generation product is identical to a Product in respect of the
infringing or allegedly infringing element or elements, then the next generation product shall be
deemed to be a Product for purposes of such section.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Proprietary Information</U>&#148; means all trade secrets and other confidential information,
know-how, inventions, proprietary inventions, formulae, models, specifications, and methodologies.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Purchaser Indemnitees</U>&#148; has the meaning ascribed to such term in <U>Section
9.02(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Purchase Price</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;1.02</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Purchasers</U>&#148; has the meaning ascribed to it in the preamble of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Purchaser DC Plans</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;5.01(h)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Purchaser FSA Plans</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;5.01(f)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Real Property</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;2.09(b)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Registered Patents and Trademarks</U>&#148; has the meaning ascribed to it in
<U>Section&nbsp;2.13(e)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Registrations</U>&#148; means authorizations, approvals, licenses, permits, certificates, or
exemptions of any Governmental Authority (including pre-market approval applications, pre-market
notifications, investigational device exemptions, product recertifications, manufacturing approvals
and authorizations, CE Marks, pricing and reimbursement approvals, labeling approvals or their
foreign equivalent) that are
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->57<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">required for the research, development, manufacture, distribution,
marketing, storage, transportation, use and sale of the Products.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Regulatory Authority</U>&#148; means, with respect to any country or jurisdiction, any
Governmental Authority involved in granting Registrations or in administering Regulatory Laws in
that country or jurisdiction, including the FDA in the United States.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Regulatory Laws</U>&#148; means all Laws governing the import, export, design, testing,
investigation, manufacture, marketing or sale of a product, or establishing recordkeeping or
reporting obligations for product complaints or adverse events, or relating to Field Actions or
similar regulatory matters.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Releasees</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;2.18</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Representatives</U>&#148; means, with respect to a Person, the directors, officers, employees,
agents or advisors (including, without limitation, attorneys, accountants, consultants, bankers and
financial advisors) of such Person.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Review Period</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;1.07(b)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Section&nbsp;338 Election</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;6.08</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Sellers</U>&#148; has the meaning ascribed to it in the preamble of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Seller DC Plans</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;5.01(h)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Seller FSA Plans</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;5.01(f)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Seller ESPPs</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;5.01(j)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Seller Indemnitees</U>&#148; has the meaning ascribed to such term in <U>Section&nbsp;9.02(b)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Seller NQ Plans</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;5.01(i)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Shares</U>&#148; has the meaning ascribed to it in the recitals of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Software</U>&#148; means all computer software programs, including operating system and
applications software, implementations of algorithms and program interfaces,
whether in source code or object code form, and all documentation, including design documents,
flowcharts, training materials and user manuals, relating to the foregoing, and all translations
thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>SNAC</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;2.02</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Spine Data Room</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;2.19</U>.
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy</div>
<P align="center" style="font-size: 10pt"><!-- Folio -->58<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Spine Entities</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;2.02</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Taxes</U>&#148; means any and all taxes, fees, levies or other assessments, including, without
limitation, federal, state, local, or foreign income, gross receipts, excise, real or personal
property, sales, withholding, social security, occupation, use, service, service use, value added,
license, net worth, payroll, franchise or similar taxes, imposed by any Taxing Authority, together
with any interest, penalties or additions to tax and additional amounts imposed with respect
thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Taxing Authority</U>&#148; means any agency or political subdivision of any federal, foreign,
state, local or municipal government entity with the authority to impose any Tax.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax Return</U>&#148; means any report, return, document, declaration or other information or
filing required to be supplied to any Taxing Authority or jurisdiction (foreign or domestic) with
respect to Taxes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Third Party</U>&#148; means any Person other than Sellers, Purchasers or any of their
respective Affiliates.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Third Party Claim</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;9.03(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Trademarks</U>&#148; means all trademarks, service marks, trade dress, logos, labels, domain
names, websites and trade names, together with all translations, adaptations, derivations and
combinations thereof and all applications, registrations and renewals in connection therewith.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Transfer Taxes</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;6.07</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Transition Services Agreement</U>&#148; has the meaning ascribed to it in <U>Section
4.11</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>U.S. Business Employee</U>&#148; means any Person who, as of immediately before Closing, is an
employee of ASI, including in all cases any such employee who is absent from work because of leave
of absence, illness, vacation, holiday or short-term disability; excluding, however, any such
Person who is absent from work because of long-term disability and any Person listed on
<U>Schedule&nbsp;10.01(c)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>U.S. Purchaser</U>&#148; has the meaning ascribed to it in the preamble of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>U.S. Seller</U>&#148; has the meaning ascribed to it in the preamble of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>U.S. Seller Pension Plans</U>&#148; has the meaning ascribed to it in <U>Section&nbsp;5.01(g)</U>.
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy</div>
<P align="center" style="font-size: 10pt"><!-- Folio -->59<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Working Capital</U>&#148; means the current assets, excluding cash and cash equivalents, of
the Business, reduced by the current liabilities (including the current portion of any indebtedness
for borrowed money) of the Business, in each case as determined consistently with the preparation
of the Financial Statements and the template set forth in <U>Schedule&nbsp;10.01(d)</U>.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE XI<BR>
MISCELLANEOUS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.01 <U>Assignment</U>. This Agreement shall be binding upon and inure to the benefit of
the parties hereto and their respective successors and assigns. No assignment shall be made by any
party without the prior written consent of the other parties hereto; <U>provided</U>,
<U>however</U>, that any party may assign its rights, but not its obligations, under this
Agreement without such Consent to an Affiliate or in connection with a sale, merger or other
transaction involving a transfer of substantially all of its assets.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.02 <U>Public Announcements</U>. On the date hereof, the parties may issue a press release
announcing the execution of this Agreement in the form attached hereto as <U>Exhibit&nbsp;B</U>. No
party hereto shall issue or make any other public announcement, press release or other public
disclosure regarding this Agreement or its subject matter without the Sellers&#146; prior written
consent, in the case of any proposed disclosure by a Purchaser, or without the Purchasers&#146; prior
written consent, in the case of any proposed disclosure by a Seller, except for any such disclosure
that is, in the opinion of the disclosing party&#146;s counsel, required by applicable Law or the rules
of a stock exchange on which the securities of the disclosing party are listed. In the event a
party is, in the opinion of its counsel, required by applicable Law or the rules of a stock
exchange on which its securities are listed to make a public disclosure other than that set forth
in <U>Exhibit&nbsp;B</U>, such party shall submit the proposed disclosure in writing as far in advance
of the disclosure as practicable, to the Sellers, in the case of any proposed disclosure by a
Purchaser, or the Purchasers, in the case of any proposed disclosure by a Seller and provide the
Sellers or Purchasers, as applicable, a reasonable opportunity to comment thereon. The contents of
<U>Exhibit&nbsp;B</U> and
any other announcement or filing or similar publicity that has been reviewed, approved and
released by the reviewing party may then be re-released by any party without a requirement for
advance notice or re-approval.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.03 <U>Severability</U>. If any provision of this Agreement is held to be illegal, invalid
or unenforceable under present or future Laws effective during the term hereof, such provision
shall be fully severable and this Agreement shall be construed and enforced as if such illegal,
invalid or unenforceable provision never comprised a part hereof; and the remaining provisions
hereof shall remain in full force and effect and shall not be affected by the illegal, invalid or
unenforceable provision or by its severance herefrom. Furthermore, in lieu of such illegal,
invalid or unenforceable provision, there
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy</div>
<P align="center" style="font-size: 10pt"><!-- Folio -->60<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">shall be added automatically as part of this Agreement, a
provision as similar in its terms to such illegal, invalid or unenforceable provision as may be
possible and be legal, valid and enforceable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.04 <U>No Third Party Beneficiaries</U>. This Agreement is for the sole benefit of the
parties hereto and their permitted assigns and nothing herein, express or implied (including
<U>Article&nbsp;IX</U>), shall give or be construed to give to any Person, other than the parties
hereto and such permitted assigns, any legal or equitable rights hereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.05 <U>Waiver</U>. The failure of any party to enforce any condition or part of this
Agreement at any time shall not be construed as a waiver of that condition or part, nor shall it
forfeit any rights to future enforcement thereof. Any waiver hereunder shall be effective only if
delivered to the other parties hereto in writing by the party making such waiver.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.06 <U>Governing Law</U>. This Agreement shall be construed and enforced in accordance
with and governed by the internal Laws of the State of Delaware without regard to the conflicts of
Laws provisions thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.07 <U> Jurisdiction</U>. The parties hereto agree that any Action seeking to enforce any
provision of, or based on any matter arising out of or in connection with, this Agreement or the
transactions contemplated hereby shall be brought in the United States District Court located in
Wilmington, Delaware so long as such court shall have subject matter jurisdiction over such Action,
or alternatively in the Delaware State Court located in Wilmington, Delaware if the aforesaid
United States District Court does not have subject
matter jurisdiction, and that any cause of action arising out of this Agreement shall be
deemed to have arisen from a transaction of business in the State of Delaware, and each of the
parties hereby irrevocably consents to the jurisdiction of such court (and of the appropriate
appellate courts therefrom) in any such Action and irrevocably waives, to the fullest extent
permitted by Law, any objection that it may now or hereafter have to the laying of the venue of any
such Action in any such court or that any such Action that is brought in such court has been
brought in an inconvenient forum. Process in any such Action may be served on any party anywhere
in the world, whether within or without the jurisdiction of such court. Without limiting the
foregoing, each party agrees that service of process on such party as provided in <U>Section
11.13</U> shall be deemed effective service of process on such party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.08 <U>Waiver of Jury Trial</U>. EACH OF THE PARTIES HERETO WAIVES TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION
DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE
TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH OF THE PARTIES HERETO HEREBY: (A)&nbsp;CERTIFIES THAT
NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
</DIV>
<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy</div>
<P align="center" style="font-size: 10pt"><!-- Folio -->61<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER;
AND (B)&nbsp;ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS
CONTEMPLATED BY THIS AGREEMENT, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND
CERTIFICATIONS IN THIS <U>SECTION 11.08</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.09 <U>Specific Performance</U>. The parties acknowledge that, in view of the uniqueness
of the Business and the transactions contemplated by this Agreement, each party would not have an
adequate remedy at Law for money damages in the event that this Agreement has not been performed in
accordance with its terms, and therefore agrees that the other parties shall be entitled to interim
relief or specific enforcement of the terms hereof in addition to any other remedy to which it may
be entitled, at Law or in equity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.10 <U>Headings</U>. The headings of the sections and subsections of this Agreement are
inserted for convenience only and shall not be deemed to constitute a part hereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.11 <U>Counterparts</U>. The parties may execute this Agreement in one or more
counterparts, and each fully executed counterpart shall be deemed an original.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.12 <U>Further Documents</U>. Each of the Sellers and the Purchasers shall, and shall
cause its respective Affiliates to, at the request of the other party, execute and deliver to such
other party all such further instruments, assignments, assurances and other documents as such other
parties may reasonably request in connection with the carrying out of this Agreement and the
transactions contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.13 <U>Notices</U>. All communications, notices and Consents provided for herein shall be
in writing and be given in person or by means of telex, facsimile or other means of wire
transmission (with request for assurance of receipt in a manner typical with respect to
communications of that type), by overnight courier or by mail, and shall become effective: (a)&nbsp;on
delivery if given in person; (b)&nbsp;on the date of transmission if sent by telex, facsimile or other
means of wire transmission; (c)&nbsp;one (1)&nbsp;Business Day after delivery to the overnight service; or
(d)&nbsp;four (4)&nbsp;Business Days after being mailed, with proper postage and documentation, for
first-class registered or certified mail, prepaid. Notices shall be addressed as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 4%; margin-top: 6pt">If to Purchasers, to:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 4%; margin-top: 6pt">Zimmer Spine, Inc.<BR>
7375 Bush Lake Road<BR>
Edina, Minnesota 55439<BR>
Attention: President &#038; CEO<BR>
Facsimile No.: 952-837-6955
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy</div>
<P align="center" style="font-size: 10pt"><!-- Folio -->62<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">with copies to:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 6pt">Zimmer, Inc.<BR>
345 East Main<BR>
Warsaw, IN 46580<BR>
Attention: Chief Legal Officer<BR>
Facsimile No.: 574-372-4302
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 6pt">and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 6pt">Baker &#038; Daniels LLP<BR>
600 East 96th Street, Suite&nbsp;600<BR>
Indianapolis, IN 46240<BR>
Attention: Daniel L. Boeglin<BR>
Facsimile No.: 317-569-4800
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 6pt">If to U.S. Seller, to:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 6pt">Abbott Laboratories<BR>
Dept. 3MDB, Bldg. AP6B<BR>
100 Abbott Park Road<BR>
Abbott Park, Illinois 60064-6112<BR>
Facsimile No.: 847-936-0353<BR>
Attn: Vice President, Licensing/New Business Development
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 6pt">with copies to:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 6pt">Abbott Laboratories<BR>
Dept. 0322, Bldg. AP6A<BR>
100 Abbott Park Road<BR>
Abbott Park, Illinois 60064-6010<BR>
Facsimile No.: 847-938-1206
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 0pt">Attn: &nbsp;&nbsp;Vice President and Associate General Counsel, Corporate<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transactions and Medical Products Legal Operations
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 6pt">and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 6pt">Skadden, Arps, Slate, Meagher &#038; Flom LLP<BR>
333 West Wacker Drive<BR>
Chicago, Illinois 60606
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 0pt">Facsimile No.: 312-407-0411
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 0pt">Attn: &nbsp;&nbsp;Charles W. Mulaney, Jr.<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Brian W. Duwe
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 6pt">If to International Seller, to:
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->63<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 6pt">Abbott France S.A.S
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 0pt">10 rue d&#146;Arceuil<BR>
BP 90233<BR>
94528 Rungis Cedex, France<BR>
Facsimile No: (33 1) 456 04 060<BR>
Attn: General Manager
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 6pt">with copies to:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 6pt">Abbott Laboratories<BR>
Dept. 0322, Bldg. AP6A<BR>
100 Abbott Park Road<BR>
Abbott Park, Illinois 60064-6010<BR>
Facsimile No.: 847-938-1206
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 0pt">Attn: &nbsp;&nbsp;Vice President and Associate General Counsel, Corporate<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transactions and Medical Products Legal Operations
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 6pt">and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 6pt">Skadden, Arps, Slate, Meagher &#038; Flom LLP<BR>
333 West Wacker Drive<BR>
Chicago, Illinois 60606
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 0pt">Facsimile No.: 312-407-0411
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 3%; margin-top: 0pt">Attn: &nbsp;&nbsp;Charles W. Mulaney, Jr.<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Brian W. Duwe
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>provided</U>, <U>however</U>, that if any party shall have designated a different address by
notice to the others, then to the last address so designated.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.14&nbsp;<U>Construction</U>. The language in all parts of this Agreement shall be construed, in all
cases, according to its fair meaning. The parties acknowledge that each party and its counsel have
reviewed and revised this Agreement and that any rule of construction to the effect that any
ambiguities are to be resolved against the drafting party shall not be employed in the
interpretation of this Agreement. Words in the singular shall be deemed to include the plural and
vice versa and words of one gender shall be deemed to include the other gender as the context
requires. The terms &#147;hereof,&#148; &#147;herein,&#148; and &#147;herewith&#148; and words of similar import shall, unless
otherwise stated, be construed to refer to this Agreement as a whole (including all of the
Schedules hereto) and not to any particular provision of this Agreement. Article, Section and
Schedule references are to the Articles, Sections, and Schedules to this Agreement unless otherwise
specified. Unless otherwise stated, all references to any agreement shall be deemed to include the
exhibits, schedules and annexes to such agreement. The word &#147;including&#148; and words of similar
import when used in this Agreement shall mean &#147;including, without limitation,&#148; unless the context
otherwise requires or unless otherwise specified. The word &#147;or&#148; shall not be exclusive. Unless
otherwise specified in a particular case, the word &#147;days&#148; refers to calendar days.
References herein to this Agreement shall be deemed to refer to this
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->64<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Agreement as of the date
of such agreement and as it may be amended thereafter, unless otherwise specified. All references
to &#147;dollars&#148; or &#147;$&#148; shall be deemed references to the lawful money of the United States of America
and all references to &#147;euro&#148; or &#147;<FONT face="'Times New Roman',times,serif">&#128;</FONT>&#148; shall be deemed references to the lawful money of the European
Union. Until such time as International Seller becomes a party to this Agreement as provided in
<U>Section&nbsp;11.15</U>, any reference to Sellers in this Agreement shall be deemed to be the U.S.
Seller. Until such time as International Purchaser becomes a party to this Agreement as provided
in <U>Section&nbsp;4.18</U>, any reference to Purchasers in this Agreement shall be deemed to be the
U.S. Purchaser.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.15&nbsp;<U>Ratification of this Agreement by International Seller</U>. The parties hereby agree and
acknowledge that International Seller shall not sign and become a party to this Agreement until the
appropriate consultation with the works councils of International Seller and ASSA has been
completed to the reasonable satisfaction of International Seller. Promptly following completion of
the appropriate consultation with the works councils of International Seller and ASSA to the
reasonable satisfaction of International Seller, U.S. Seller shall cause International Seller to
execute a copy of this Agreement and shall become bound by this Agreement. Upon International
Seller signing this Agreement and becoming a party to this Agreement, International Seller shall be
entitled to all and any rights, benefits and remedies, and shall be bound by all the obligations,
of any nature whatsoever under, or by reason of, this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.16&nbsp;<U>Exchange Rates</U>. If applicable Law requires that the portion of the Purchase Price
allocated to the ASSA Shares must be stated in Euro for purposes of paying any Transfer Taxes or
for any other purposes, then the parties shall use for such purposes the exchange rate between
dollars and Euro as reported on the Bloomberg Screen at 7:00 am EDT on the Closing Date. In
addition, in the event that the parties need to convert Euro or any other local currencies into
dollars for purposes of preparing the Closing Working Capital of ASSA or the Final Working Capital
of ASSA, the relevant exchange rate between dollars and the applicable local currency will be
determined based on the rate three (3)&nbsp;Business Days preceding the applicable determination date as
published in the Financial Times under the heading &#147;<I>Currencies and Interest Rates&#148; </I>of the &#147;<I>Dollar
Spot Forward Against the Dollar&#148; </I>tables, in the column &#147;<I>Closing mid-point&#148;.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.17&nbsp;<U>Entire Agreement</U>. This Agreement, the Confidentiality Agreement and the Transition
Services Agreement constitute the entire agreement among the parties and supersedes any prior
understanding, agreements, or representations by or among the parties, written or oral to the
extent they relate in any way to the subject matter hereof.
</DIV>
<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->65<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, this Agreement has been executed and delivered by the authorized officers
of U.S. Purchaser and U.S. Seller as of the date first above written and of International Purchaser
and International Seller as of the date written below.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="44%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">ZIMMER, INC.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:<BR>
Name:<BR>
Title:<BR>
Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Chad F. Phipps
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Chad F. Phipps <BR>

SVP, General Counsel &#038; Secretary <BR>

September&nbsp;4, 2008
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">ZIMMER HOLDINGS FRANCE S.A.S.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2008</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ABBOTT
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LABORATORIES</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Thomas C. Freyman</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Thomas C. Freyman</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Executive Vice President, Finance
&#038; Chief Financial Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">September&nbsp;4, 2008</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">ABBOTT FRANCE S.A.S.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2008</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT A<BR>
TRANSITION SERVICES AGREEMENT
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT B<BR>
PRESS RELEASE
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Execution Copy
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
